Tissue regulation of dendritic cells : with focus on chemokines, function and migration by Nguyen Hoang, Anh Thu
Center for Infectious Medicine, Department of Medicine 
Karolinska Institutet, Stockholm, Sweden 
 
 
 
 
 
TISSUE REGULATION OF DENDRITIC CELLS: 
 
with focus on chemokines, function and migration   
 
 
 
Anh Thu Nguyen Hoang 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stockholm 2013  
  
All published papers were reproduced with permission from the publisher. 
 
Published by Karolinska Institutet 
Printed by Larserics Digital Print AB 
 
© Anh Thu Nguyen Hoang, 2013 
ISBN 978-91-7549-176-9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Wherever you go,  
          go with all your heart” 
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ABSTRACT 
 
Tissue-specific cells, such as fibroblasts and epithelial cells in local microenvironments 
have been recognized to influence the function and phenotype of hematopoietic cells, 
such as dendritic cells (DC). The interaction and cooperation between DC and the cells 
of the tissue is important for the maintenance of immune homeostasis as well as 
orchestrating immune responses against pathogens. However, a majority of studies on 
human DC are performed under conditions absent of a relevant physiological milieu 
allowing interactions between different cell types. Thus, there is a need to develop in 
vitro human tissue models with immune cells that can capture cellular responses under 
conditions similar to those found in real tissue. In my thesis work, I have developed a 
human three-dimensional (3D) lung tissue model that has morphological and functional 
features mimicking those of human lung epithelial tissue. The model has a stratified 
epithelial layer with human DC that are situated closely to the epithelium and an 
underlying collagen matrix rich in fibroblasts. We have found that the lung tissue 
model supports DC survival for at least eleven days in the absence of exogenous 
growth factors. The tissue model also regulates chemokine production by DC leading to 
enhanced production of CCL18 and downregulation of CCL17 and CCL22, which 
resemble chemokine production under physiological conditions in lung tissue. In 
addition, using live cell imaging, we could observe that stimulation with toll-like 
receptor-ligands and CCL2 attracted DC to the epithelial layer as well as increased their 
speed and their ability to survey a larger area in the tissue model. We also found, using 
our newly established 3D tumour spheroid tissue model of non-small cell lung cancer, 
that DC are recruited to the tumour area and engulf tumour cells more readily than 
normal epithelial cells.  
Another major focus of this thesis work is the study of stromal cell-derived 
chemokines supporting regulatory DC development during L. donovani infection. 
Stromal cells are known to regulate hematopoiesis in the bone marrow and spleen by 
secretion of chemokines, cytokines and growth factors.  Studies have shown that 
murine splenic stromal cells have the ability to support differentiation of hematopoietic 
stem and progenitor cells (HSPC) into regulatory DC and this ability is enhanced 
during L. donovani infection. We further showed that stromal cell-derived chemokines 
CXCL12 and CCL8 cooperate to recruit HSPC with the ability to differentiate into 
regulatory DC. In addition, we observed that direct infection of MBA-1 cells by L. 
donovani enhanced their ability to support regulatory DC as well as their ability to 
produce CCL8. Interestingly, CCL8 expression was strongly induced in splenic stromal 
cells of mice infected with L. donovani, which enhanced their ability to attract HSPC.  
Our findings suggest that L. donovani infection modulates the ability of stromal cells to 
recruit and support HSPC differentiation into regulatory DC, and this may be a 
mechanism used by the parasite to establish persistent infection.  
Together, the studies in this thesis show the impact of tissue specific cells on DC 
differentiation and function, and highlights the importance of taking into account 
tissue-specific components when studying DC biology. 
POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Vävnadsreglering av dendritceller:  
med fokus på kemokiner, funktion och migration 
 
Dendritceller (DC) finns i alla kroppsvävnader och är viktiga för att generera ett starkt 
immunsvar mot bakterie- och virusinfektioner. Dessa celler är immunsvarets bevakare 
och har som uppgift att söka efter farliga inkräktare, till exempel bakterier och virus, 
som kan orsaka sjukdomar. När DC upptäcker ett hot mot kroppen, som vid en 
bakterieinfektion, tar de med sig delar av bakterien och presenterar det för 
immunförsvarets soldater som kallas för T-celler. Presentationen av bakterien leder till 
att T-cellerna blir aktiverade och ökar i antal, för att sedan förflytta sig till den 
infekterade vävnaden där de kan hjälpa till att eliminera dessa farliga bakterier. Denna 
immunologiska process är mycket viktig för att skydda oss mot alla typer av 
infektioner. Dendritceller har också en annan viktig uppgift; de kan presentera det som 
är kroppseget för T-celler, vilket gör att T-cellerna lär sig att känna igen det som är 
kroppseget och inte blir reaktiva mot kroppens egna celler och vävnader. Därför är DC 
både viktiga för att hjälpa till vid infektioner och för att upprätthålla den 
immunologiska balansen i kroppen. Forskning har visat att DC inte är ensamma i sina 
uppdrag utan får instruktioner från vävnadspecifika celler såsom fibroblaster och 
epitelceller. Dessa celler är viktiga då de bidrar till att upprätthålla strukturen och 
funktionen hos vävnaden. Samtidigt har forskningen också visat att vävnadspecifika 
celler kan påverka och interagera med DC för att hjälpa till att upprätthålla den 
immunologiska balansen och reglera immunsvar mot patogener. Därför är det viktigt 
att kunna studera DC i en mikromiljö som efterliknar den som finns i riktig vävnad. De 
flesta studier på humana DC har dock utförts i odlingsflaskor som saknar viktiga 
vävnadsspecifika celler och en mikromiljö som omger DC i riktig vävnad. Forskning på 
DC som är baserad på in vivo data har utförts på möss, vilka har visats vara användbara 
modellsystem för att ge en bättre förståelse för mänskligt immunförsvar. Men på grund 
av att många patogener endast infekterar människor kommer djurmodeller inte att 
kunna ge fullständig förståelse för hur ett mänskligt immunsvar fungerar.  
Därför har jag, i detta avhandlingsarbete utvecklat en in vitro human tre-
dimensionell lungvävnadsmodell som består av DC, fibroblaster och epitelceller. 
Denna modell möjliggör studier av DC i en mikromiljö som efterliknar den som finns i 
riktig lungvävnad. Jag har visat att lungvävnadsmodellen kan stödja DCs överlevnad i 
minst elva dagar, till skillnad från DC odlade i ett cellodlingsmedium; dessa överlever 
endast i några dagar. Vi har observerat att vävnadsmodellen även kan påverka DC:s 
förmåga att producera molekyler, så kallade kemokiner som kan attrahera andra celler. 
Dendritceller i modellen har även kunnat följas i realtid med hjälp av ett fluorescens 
mikroskop där vi har observerat att DC i modellen reagerar på inflammatoriska stimuli, 
vilket leder till att de migrerar fortare och har en ökad förmåga att övervaka ett större 
område i vävnaden. Vår vävnadsmodell har också visat sig vara användbar för att 
studera DCs interaktion med tumörceller. I detta avseende har vi utvecklat en 
tumörvävnadsmodell och observerat att DC i denna modell attraheras till tumörområdet 
och tar upp tumörcellerna mer frekvent än vad de attraheras av och tar upp normala 
epitelceller. 
I detta avhandlingsarbete har jag också studerat hur vävnadsspecifika celler som 
fibroblaster påverkar regulatoriska DCs utveckling vid infektion av parasiten 
Leishmania donovani. Regulatoriska DC är celler som har förmåga att dämpa 
immunförsvaret och är viktiga för att upprätthålla den immunologiska balansen. Men 
forskning har visat att vid en kronisk infektion, som orsakas av den ovan nämnda 
parasiten, ser man en ökad produktion av regulatoriska DC. Denna ökade produktion 
visade sig bero på att infektionen ledde till att fibroblaster fick en ökad förmåga att 
kunna stödja utvecklingen av stamceller till regulatoriska DC. Vilka faktorer som 
produceras av fibroblaster för att möjliggöra denna process var dock okända. Därför har 
vi, i detta arbete, studerat huruvida kemokiner, som utsöndras av fibroblaster har 
förmåga att bidra till utvecklingen av regulatoriska DC. Vår studie visade att två 
kemokiner, CXCL12 och CCL8, samverkar för att stödja rekrytering av stamceller som 
har förmåga att utvecklas till regulatoriska DC. Vi kunde också observera att CCL8 
uttrycket i fibroblaster ökade vid parasitinfektion och detta ledde till en ökad förmåga 
hos fibroblasterna att rekrytera stamceller. Resultat av våra studier indikerar att 
infektion med L. donovani ökar fibroblasternas förmåga att rekrytera och stödja 
utvecklingen av stamceller till regulatoriska DC, vilket skulle kunna vara en mekanism 
med vilken parasiten dämpar immunförsvaret och etablerar en kronisk infektion. 
Sammantaget visar arbetena i avhandlingen att vävnadsspecifika celler spelar en 
viktig roll för DCs utveckling och funktion samt lyfter fram vikten av att studera DC 
tillsammans med vävnadsspecifika cellerna och dess komponenter. En ökad förståelse 
av DCs reglering i vävnad möjliggör att vi kan utveckla nya målinriktade 
behandlingsstrategier som syftar till att styra DC cellers funktion vid sjukdomar som, 
exempelvis, kronisk infektion och inflammation, samt cancer. 
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1 INTRODUCTION TO THE THESIS 
The immune system is a delicate network of cells that interact and cooperate with each 
other to maintain tissue homeostasis in the body as well as regulate immune responses 
to pathogens.  Within the tissue, immune cells are in close contact with tissue-specific 
cells such as stromal cells, i.e. fibroblasts, and epithelial cells. The tissue-specific cells 
play important roles in the immune system by creating tissue specific niches and 
secrete chemokines and cytokines that regulate hematopoietic cell differentiation and 
function [1]. For example tissue specialized niches in the bone marrow and spleen, are 
recognized for their important function supporting homing, migration, proliferation and 
differentiation of hematopoietic stem and progenitor cells (HSPC) into terminally 
differentiated blood cells [2]. In this context, chemokines secreted by stromal cells are 
crucial for the regulation of HSPC homing and migration between the circulation and 
peripheral tissues and organs [1]. At peripheral sites, tissue also has the ability to shape 
the phenotype and regulate functional properties of hematopoietic cells, such as DC, 
and thereby influence the outcome of immune responses [3, 4]. An increased 
understanding of the mechanisms involved in tissue-specific regulation of DC 
differentiation and function may enable the development of potential strategies to 
restore tissue homeostasis in chronic inflammatory and infectious diseases as well as 
cancer.  
The work of this thesis is based on four studies. In the first three studies, I 
investigated how the lung tissue microenvironment regulates and influences DC 
function and migratory behaviour, as well as DC interaction with tumour cells. This 
was approached by establishing and using a 3D tissue model, so-called organotypic 
model, of human lung. In the fourth study I explored the role of stromal cell-derived 
chemokines in supporting the migration of HSPC that have the ability to differentiate 
into regulatory DC during L. donovani infection. Common for all studies is that there is 
a specific focus on chemokines. Overall the thesis includes studies on the role of 
chemokines in directing DC migration in lung tissue, and how the lung tissue 
influences DC production of chemokines, as well as the role of chemokines in 
supporting the development of regulatory DC differentiation in steady state and in 
response to infection. The following two sections will give a brief introduction to the 
studies of this thesis. 
 
 
1.1 INTRODUCTION TO THE STUDY OF THREE-DIMENSIONAL LUNG 
TISSUE MODELS WITH DENDRITIC CELLS 
Dendritic cells belong to a heterogeneous population of innate immune cells and are 
widely distributed in all tissues [5]. The main functions of DC are to initiate and 
orchestrate immune responses to pathogens, as well as maintain immune homeostasis 
and tolerance to self [6, 7]. The orchestration of immune responses in the local 
microenvironment by DC includes production of cytokines and chemokines that are 
important in the activation and recruitment of other inflammatory cells with specific 
effector functions [8]. However, most studies on human DC functions have been 
performed culturing cells on plastic surfaces in tissue culture flasks that lack the 
multicellular interactions and extracellular matrix components, present in real tissues. 
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Alternatively studies on DC have been performed in animal models and, there is 
extensive data from in vivo studies of DC function in animal models, which can provide 
important knowledge also about human immune responses, but have limitations 
because many pathogens are species specific. In addition, there are molecules with no 
homologues counterparts in mice, and some molecules may even have different target 
cell populations in different species [9]. Thus, there is an increasing need to study 
human hematopoietic and non-hematopoietic interactions in a multicellular 
environment that resemble in vivo tissue to increase our understanding on the cellular 
processes that occur in a human setting. However, to investigate DC function in human 
tissues, such as lung tissue, is difficult. Therefore, the over all aim of the first part of 
this thesis was to establish a 3D organotypic lung tissue model with DC and investigate 
the regulation of the tissue microenvironment on DC function. The first aim was to 
establish a 3D lung tissue model with DC suitable to investigate the regulation of DC 
chemokine production by the lung microenvironment. As a second aim, the 3D tissue 
model was further developed for live cell imaging analysis to study DC migration in 
response to inflammatory stimuli and chemokines in the tissue model. The third aim 
was to develop the 3D lung tissue model further and make an organotypic-based 
epithelial spheroid tissue model of human non-small lung cancer, which could be used 
to study DC interactions with cancer cells in a multicellular system. 
 
 
1.2 INTRODUCTION TO THE STUDY OF STROMAL CELL-MEDIATED 
DEVELOPMENT OF REGULATORY DENDRITIC CELLS 
Under homeostatic conditions, HSPC are most abundant in the bone marrow and are in 
close contact with stromal cells that can regulate the homing, migration and 
differentiation of HSPC [10, 11]. In response to infection by L. donovani, increased 
hematopoietic activity has been observed, followed by altered function of splenic 
stromal cells leading to increased ability to support the differentiation of HSPC into DC 
with regulatory properties [12, 13]. Similar changes have also been reported in other 
experimental infections, such as malaria [14]. However, stromal cell-derived factors 
that are responsible for the development of regulatory DC at steady state and in 
response to chronic infections is still unknown. By increasing our understanding on the 
mechanisms by which stromal cells support the differentiation and function of 
regulatory DC, we may discover potential targets for manipulating the DC repertoire to 
reverse the course of chronic infections and restore tissue homeostasis.  Therefore, the 
fourth aim of this thesis was to investigate which stromal cell-derived chemokines may 
play a role in the recruitment of HSPC with the potential to develop into regulatory DC 
during homeostasis and in response to L. donovani infection.  
 
 
1.3 STRUCTURE OF THE THESIS  
The Introduction (Chapter 1) of this thesis is followed by the Background (Chapter 2), 
which will start with a brief background of DC function in the immune system. The 
following section will examine the importance of tissue specialized niches in the 
regulation of DC differentiation and function. This section will also point out the 
importance of studying immune cells in a more complex multicellular 
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microenvironment and argue the needs for an approach of using in vitro 3D tissue 
models with human immune cells. The next section will give an overview of 3D tissue 
culture systems and how they are generated. The last section will give a description of 
chemokine function in the immune system and emphasize the relationship between 
chemokines and DC in tissue. In the Research design (Chapter 3), the approach to 
develop a 3D in vitro lung tissue model for studying tissue-specific regulation of DC 
function and behaviour, will be described. This chapter will also describe the 
methodological approach used for dissecting stromal-derived chemokines that may play 
important role in supporting the development of regulatory DC. Following on chapter 
3, the Aims of this thesis (Chapter 4), will outline the hypotheses and aims of the thesis. 
Thereafter, the Results generated in this thesis work (Chapter 5) are presented, and this 
chapter follows by the Discussion of the results generated in this thesis (Chapter 6), and 
the Conclusion (Chapter 7).   
 
 
  4 
2 BACKGROUND 
In this chapter I give a brief background to my thesis work, and the first section of this 
chapter is a general overview of DC biology. This is followed by a section emphasizing 
the importance of tissue-specific non-immune cells as regulators of DC differentiation 
and function in health and disease. Thereafter, I discuss the significance of performing 
studies on human DC function using three-dimensional tissue models, so-called 
organotypic models, and at the end of the chapter I will provide an overview of 
chemokines focusing on their role in the immune system. 
 
 
2.1 DENDRITIC CELLS 
2.1.1 Function 
Dendritic cells belong to a heterogenous family of hematopoietic cells with 
professional antigen presenting skills and are often described as “gatekeepers of the 
immune system”, as well as the key link between innate and adaptive immunity [15-
17]. In 2011, Ralph Steinman was awarded the Nobel Prize in Medicine and 
Physiology for his pioneering work on the importance of DC linking innate and 
adaptive immunity [16]. By, patrolling peripheral tissues, DC are among the first cells 
to recognize pathogens via a specialized set of pattern recognition receptors. Upon 
recognition of pathogens, DC undergo a process of cellular activation, so-called 
maturation, including phenotypic and functional alterations. This includes, for example 
upregulation of the chemokine receptor CCR7, costimulatory molecules CD80, CD86 
and MHC class I and II peptide complexes. Upon maturation, altered chemokine 
receptor expression directs DC to migrate from the site of infection to the secondary 
lymphoid tissues, where they present pathogen-derived peptides on their MHC 
molecules to T cells [6]. Activated DC expressing high levels of costimulatory 
molecules and MHC/peptide complexes, in combination with increased secretion of 
cytokines have the ability to initiate T cell priming and differentiation of antigen-
specific T cells [6].  The proper activation of specific T cell effector functions, e.g., 
Th1, Th2 and Th17, mediate protective immunity against infections, and possibly 
tumours [18-20]. Dendritic cells are also important in controlling inflammation-induced 
immunopathology through the generation of antigen-specific regulatory T cells [21, 
22]. Among these are the IL-10 [23] and TGF-β producing regulatory T cells [24, 25] 
that possess inhibitory function on immune effector mechanisms. In addition, DC 
orchestrate immune responses at local sites of infection [5] and furthermore, the tissue 
where DC originate from as well as the mode and context of DC activation, appear to 
be highly relevant for the outcome of T cells responses, including T cell-specific 
homing properties [26, 27].  
Although, clearly demonstrated, the ability to induce and regulate immune responses 
is a pivotal function of DC, another fascinating role of DC is to maintain immune 
homeostasis and tolerance to self. In this context, DC capture non-harmful antigens 
from the tissue microenvironment, for example in the respiratory and digestive tracts 
[28], or self antigens from tissues [29]. The capture of environmental proteins in steady 
state in the absence of microbial stimuli and DC maturation allow DC to maintain 
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immune tolerance to self by inducing peripheral T cell tolerance. Tolerance to self and 
environmental non-harmful proteins is crucial for maintaining immune homeostasis [7].  
 
2.1.2 Classification 
In order to fulfil their various tasks in the immune system DC are plastic in nature, and 
can be instructed by the surrounding tissue microenvironment, but there are also several 
different subsets of DC that develop independently, have overlapping functions but also 
unique features. Studies deciphering DC heterogeneity has mostly been performed in 
mice, and mouse DC are today usually divided into four major subsets based on their 
surface marker expression and functional properties: conventional DC (cDC), 
Langerhans cells, plasmacytoid DC and inflammatory DC [30].  
Conventional DC dominate at steady state and are specialized in antigen processing 
and presentation. There are two major groups of cDC: lymphoid tissue-resident DC and 
migratory DC. The lymphoid tissue-resident DC are the most studied DC in mice and 
are located in spleen, lymph nodes and thymus. These cells can be further divided into 
two groups: CD8+ and CD11b+ DC [31] (Figure 1). Their location in lymphoid tissues 
allows them to sense antigens or pathogens that are transported in the blood. The 
migratory DC populate the peripheral tissues such as skin, intestines and lungs. They 
comprise two main groups in mice: CD11b+ DC and CD103+ CD11b− DC [32].  Tissue 
CD103+ DC originate from the same precursor as the lymphoid tissue CD8+ DC and 
they share similar functions. The CD103+ DC are specialized in sensing pathogens and 
tissue damage and have a critical role in the induction of cytotoxic CD8+ T cells [33]. 
On the other hand the CD11b+ DC express high levels of MHC class II molecules [34] 
and are important for mounting CD4+ T cell immune responses [35].  
Langerhans cells are DC that populate the epidermal layer of the skin [36]. They are 
resident in the skin but can also migrate to the lymph nodes to present antigen. Contrary 
to most of the DC that are derived from HSPC in the bone marrow, Langerhans cells 
originate from a local precursor cell population in the skin. Their precise function in the 
immune system is not fully understood. They can induce regulatory T cells [37] and 
Th17 T cells, but do not mount Th1 responses [38].  
Plasmacytoid DC are widely distributed in the body and are recognized by their 
ability to produce large amounts of type I interferons in response to viral infections. 
Although, their precise role in shaping immune responses still needs to be elucidate, 
they are important for, antiviral immunity, but have also been implicated in 
autoimmune diseases [39].   
Inflammatory DC are derived from monocytes [40] or early hematopoietic 
precursors [41, 42] in response to microbial or inflammatory stimuli. These cells have 
similar characteristics to conventional DC and express CD11c, MHC class II molecules 
and DC-specific ICAM3-grabbing non-integrin (DC-SIGN, also known as CD209a) 
[43]. They are potent antigen-presenting cells and can cross-present antigens, therefore 
they are thought to serve as a crucial reservoir of professional antigen presenting cells 
during acute infections [43] [40, 44].  
In humans, DC populations show basic similarities to the four subsets described in 
mice. For technical and ethical reasons the most abundantly studied population of DC 
are those found in blood or those derived from monocytes, followed by residing in skin 
DC. [30].  
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Conventional DC in human blood are characterized as Lin−MHC-II+CD11c+ [45], 
although CD11c is also expressed on monocytes and macrophages in humans. 
Conventional DC in humans share similar functions to mouse cDC, however, their 
surface markers are different [46]. The blood cDC in humans can be subdivided into 
two major population: CD1c+ and CD141+ DC [47, 48].  Studies of cDC in the non-
lymphoid tissues has been performed using tissue explants from patients with 
underlying diseases, which could influence the composition of tissue DC. By earlier 
studies on human dermis, two cDC populations have been identified: CD1a+CD14− and 
CD1a−CD14+ DC [49, 50]. Recent studies have also identified one population of cDC 
that expresses CD1c+ in the dermis [51] and another population that expresses CD141+ 
in dermis [51], lungs, kidney and intestines [52]. In lymphoid tissues, such as spleen 
and tonsils, CD1c+ and CD141+ DC that resemble the blood DC have been found [53, 
54] and likely are corresponded to lymphoid tissue resident DC. CD141+ DC have 
equivalent antigen cross-presenting function as mouse CD8+ and CD103+ DC, whereas 
human CD1c+ DC are more related to mouse CD11b+ DC [55]. 
Langerhans cells are the dominant hematopoietic cells in human epidermis and can 
be easily identified by their expression of epithelial cell adhesion molecule (EPCAM), 
langerin [56] and CD1a [57].  In humans Langerhans cells have been shown to induce 
proliferation of epidermal-resident regulatory T cells at steady state, but limit the 
activation of regulatory T cells during inflammation. This would suggest a role for 
these cells both in the maintenance of homeostasis as well as in the regulation of 
immune responses [37].  
Plasmacytoid DC have been characterized as CD303+CD304+ in human blood and 
share similar functions to the mouse pDC [39]. 
Inflammatory DC in humans are also thought to be generated from monocytes but 
the sequence of events leading to monocyte differentiation in vivo are difficult to study. 
Therefore relatively little is known how potential monocyte-derived DC participate in 
immune responses during bacterial infections and inflammatory reactions. However, 
some recent experimental evidence from studies on rheumatoid artritis and cancer 
patients points towards monocytes being the source of human inflammatory DC. These 
DC share similar features with blood CD141+ DC and inflammatory macrophages and 
have the ability to induce Th17 immune responses [58]. 
 
2.1.3 Dendritic cell function in immune homeostasis and tolerance 
The immune system has important control mechanisms to limit the magnitude of 
inflammatory responses and thereby avoid destruction of healthy tissue. DC have an 
important role in controlling immune responses by exerting regulatory functions to 
maintain immune homeostasis and tolerance [7]. During steady state, DC have the 
ability to induce both central and peripheral T cell tolerance. Initial experiments have 
suggested that immature DC can induce tolerance by presenting antigens in the absence 
of costimulation, which could lead to T cell deletion or generation of regulatory T cells 
[59-61]. However, recent studies have shown that fully matured DC also acquire 
regulatory function and can induce tolerance [62-66]. This suggests that the definition 
of regulatory DC depends on their functional status rather than a specialized 
subpopulation defined by phenotypical markers. The functional state of DC depends on 
their ability to respond to environmental signals from different microenvironments 
[67]. It has become evident that regulatory DC are induced in chronic infections, which  
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could indicate that pathogens utilize the tolerogenic properties of DC to evade the host 
immune response [12, 14, 68, 69]. 
 
2.1.4 Toll-like receptors – sensors on dendritic cells 
DC patrol throughout the body and act as sentinels of the immune system. To perform 
this task, DCs express a range of microbial recognition receptors that can bind 
conserved molecular patterns expressed by the pathogens. Amongst the innate immune 
recognition receptors, toll-like receptors (TLRs) have a key role in microbial detection 
and initiation of innate immune responses. In 2011, Jules Hoffman and Bruce Beutler 
shared the Nobel Prize with Ralph Steinman, for their work, which led to the 
identification of TLRs and their importance in innate immune activation [16, 70, 71]. 
At least ten TLRs have been characterized in mammalian species and TLRs are highly 
expressed on DCs, with some differences between distinct DC subsets [72] (Table 1). 
Each TLR is specialised in the recognition of different microbial molecular patterns. 
TLR 1,2,4,5, and 6 recognize bacterial products, while TLR 3,7,8 and 9 detect viral 
components and nucleic acids [73]. Bacterial and viral products recognized by TLRs 
include LPS that binds TLR4, bacterial lipoproteins that bind TLR1 and 2, flagellin that 
Figure 1. The illustration depicts an overview of DC development, starting from the hematopoietic stem 
cells (HSC) to the common myeloid progenitors (CMP), macrophage DC progenitors (MDP), common 
DC progenitors (CDP), circulating DC progenitors (pre-DC) and monocytes. The hematopoietic stem 
and progenitor cells (HSPC) that have been studied in this thesis is composed of HSC, CMP and MDP. 
Progenitors for Langerhans cells have been shown to populate the skin prior to birth, however, the origin 
of those cells remains unknown. Plasmacytoid DC (pDC). 
 
Figure 1 
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binds TLR5, CpG DNA of bacteria and viruses that bind TLR9, double-stranded RNA 
that bind TLR3 and single-stranded viral RNA that bind TLR7 [74, 75]. Regardless of 
subset TLR-signalling induce both phenotypic and functional maturation of DC. The 
production of inflammatory cytokines including IFN-α, IFN-β, IL-12, TNF-α, IL-6 and 
IL-1 [76] may, however, differ in magnitude depending the DC subset investigated.  
 
 
Table 1. TLR expression by human DC subsets 
                       In vitro- 
                   Freshly isolated              differentiated DC 
 
 DC       pDC                  CSF-2 + IL-4 
 
TLR1 
TLR2 
TLR3 
TLR4 
TLR5 
TLR6 
TLR7 
TLR8 
TLR9 
TLR10 
 
+ 
+ 
+ 
– 
+ 
+ 
+ 
+ 
– 
+ 
 
 
+ 
– 
– 
– 
– 
+ 
+ 
– 
+ 
+ 
 
+ 
+ 
+ 
+ 
+/– 
+ 
– 
+ 
– 
 
Table 1. Adapted from Iwasaki et al. Nature Immunol. 2004;5: 987-995.  
 
 
2.1.5 Dendritic cell function during acute inflammation 
During acute microbial infection, there is an increased recruitment of monocytes from 
the bone marrow to the blood, and monocytes in circulation migrate to infected and 
inflamed tissue where they can differentiate into DC with inflammatory properties [44]. 
However, inflammatory DC can also be differentiated from early hematopoietic 
progenitors as mentioned before. However, it remains to be explored whether the 
generation of inflammatory DC differ quantitatively or qualitatively depending on 
where the DC originate from [30]. The inflammatory DCs play a crucial role in the 
control of early antimicrobial infection by secreting nitric oxide (NO) and tumor 
necrosis factor (TNF). Especially, one population of monocyte-derived DC, called 
TipDC (TNF-iNOS producing), are responsible for TNF and iNOS production during 
the first three days of systemic infection and have a crucial role in the innate immune 
defences [77-79]. Inflammatory DC are suggested to have an important back-up role 
during infection and are important in the clearance of bacterial and parasite infections 
such as Brucella melitensis, Leishmania major, Listeria monocytogenes, and 
Trypanosoma brucei infection [40]. 
Although, there are many different subsets of DC in the human body, DC generated 
from blood monocytes have been widely used in many studies because they are readily 
available.  The method of generating a large number of DC from monocytes in vitro 
[80] using CSF-2 and IL-4, has facilitated the studies on human DC. In vitro monocyte-
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derived DC were believed to resemble the inflammatory DC, first of all, because CSF-2 
have been thought to promote the development of inflammatory DC in vivo. Second, 
Monocytes have mostly been studied for their role as precursors of inflammatory DC 
during infection. However, recent studies suggest a role for CSF-2 also as a steady state 
cytokine that promotes survival and homeostasis of DC in non-lymphoid tissues, while 
being less important for the generation of inflammatory DC [81]. Also, monocytes have 
been recognized to be important for the generation of steady state DC in the lung, 
spleen, skin and intestines [40]. Although, monocyte-derived DC often gets to represent 
all human DC, it is important to remember the existence of distinct subsets of DC, and 
depending on the questions addressed it may be relevant to seek alternative sources of 
human DC to get an appropriate reflection of the DC capabilities investigated. 
Regardless of their origin it is obvious that DC populations are located along side all 
epithelial linings of body surfaces, e.g., airways, skin, gut, etc, where they can be 
activated in response to foreign material and tissue damage, followed by the 
coordinated production of cytokines and chemokines [5] (Figure 2). In tissue, the 
capacity of DC to orchestrate immune responses is tightly regulated by the tissue 
microenvironment. In this context, it has become evident that lung tissue homeostasis 
requires proper tissue regulation of DC [3]; and when this balance is broken immune-
mediated tissue pathology can occur as a consequence [82]. 
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2.2 TISSUE REGULATION OF DENDRITIC CELLS  
Tissue-specific non-immune cells such as fibroblasts (stromal cells) and epithelial cells, 
are some of the important cellular components that form the tissue microenvironment 
in which DC are situated and need to function properly.  
 
2.2.1 Epithelial tissue and their cellular components 
2.2.1.1 The structure of epithelial tissue 
A typical epithelial tissue of body surfaces, e.g. intestine, lung, and skin consists of a 
stratified epithelium that grows on a basement membrane and a stromal matrix of 
fibroblasts, endothelial cells, muscle cells, and lymphatic vessels (Figure 3). The 
epithelial layer at the apical side is exposed to the outer environment and act as a 
protective barrier against external intruders. From the basal side, epithelial cells are 
attached to the basement membrane and receive their nutrition from the underlying 
stroma. The basement membrane functions as a supportive scaffold for the epithelium 
and regulates the transport of selective compounds that enter the epithelium from the 
underlying tissue [83]. The extracellular matrix (ECM) of the stroma constitutes 
structural proteins including collagens, proteoglycans, elastin and laminin, which 
provides mechanical support and works as a scaffold for tissue and cells [83]. The 
ECM also serves as a storage depot for growth factors, chemokines and cytokines [84]. 
Within this dynamic microenvironment, there is a constant interaction between immune 
cells and the surrounding tissue cells. They communicate and cooperate through the 
secretion of chemokines and cytokines and together they orchestrate tissue homeostasis 
and regulate immune responses. 
 
2.2.1.2 Epithelial cells 
Epithelial cells originate from the ectoderm and endoderm of the embryo [83]. To form 
a proper epithelial cell barrier, epithelial cells are tightly joined together by junctional 
complexes, including tight, adherence and gap junctions to form a sheet of tissue called 
epithelia. These epithelial sheets coat many organ surfaces such as skin, intestine and 
lung, and act as a boundary between tissue and the outer environment. Epithelial cells 
have many essential functions including protecting the tissue from external danger, 
regulation of cellular permeability, secretion of hormones and transportation of ions, 
oxygen and nutrients [83]. Thus, epithelia cell barriers are associated with major 
functional roles of different tissues, such as hepatocytes and liver metabolism, 
keratinocytes and the barrier properties of skin and alveolar epithelial cells and gas 
exchange in the lungs. The development of a well-organized epithelium in vivo 
strictly depends on epithelial interactions with the connective tissue. Thus, 
transplantation studies have revealed that morphogenesis and differentiation of 
epithelia is influenced by the underlying mesenchyme [83]. 
Figure 2. This illustration shows DC location in peripheral tissues, such as skin, lung and intestine and 
highlights the important function of DC in the regulation of adaptive immunity. In peripheral tissues, DC 
capture antigens and migrate to the draining lymph node where they present antigens to T cells and 
either induce tolerance or immune responses against pathogens, depending on the nature of the antigen. 
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The epithelium can be characterized based on their structure, which is also related to 
their function in different anatomical sites [83]. For example, stratified squamous 
epithelium in the skin and esophagus functions as a protective barrier, simple columnar 
epithelium in the intestine usually involves in secretion and absorption, pseudostratified 
epithelium in the trachea act as a regulatory barrier allowing transport of selective 
substances and cuboidal epithelium in glandular duct and kidney transports material 
into or out of the lumen. In common with the hematopoietic system and distinct from 
the stromal tissues, epithelial cells are constantly regenerated. This process may be 
rapid, as in the intestines and epidermis, or slow, as in liver and pancreas. The 
regeneration of epithelial cells is suggested to relay on stem cells that exist in the basal 
layer of the epidermis or in the crypts of the intestines [83]. 
Figure 3. This illustration shows a basic structure of the epithelial tissue with a stratified epithelial layer 
rested on a basement membrane and an underlying stromal matrix consisted of fibroblasts and immune 
cells, such as dendritic cells. Epithelia that cover organs such as skin and lungs are exposed to the outer 
environment and receive nutrition from the underlying stroma, which also provides physical support and 
interacts with the epithelial layer and immune cells through soluble signals. The extracellular matrix of 
the stroma comprises of structural proteins such as collagens, fibronectin, laminin and proteoglycans, 
which together form a supportive scaffold for the cells and also function as a storage depot through their 
ability to bind growth factors, cytokines, chemokines and other molecules.   
 
Figure 3 
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2.2.1.3 Fibroblasts 
Fibroblasts originate from mesenchymal cells [85] and consist of a heterogeneous 
family of cells, depending on their location in different tissues. For example, fibroblasts 
isolated from different anatomical sites of the body are highly diverse in their gene 
expression patterns of extracellular matrix proteins and growth factors. Chang et al. 
showed that fetal fibroblasts from the skin expressed high level of collagen I and V, 
whereas fetal lung fibroblasts expressed lung specific transcription factors FOXF1 and 
FOXP1 [86]. Furthermore, adult fibroblasts maintained HOX gene expression that was 
established during embryogenesis, which may direct topographic differentiation and 
positional memory in fibroblasts [86]. In tissue, fibroblasts, are the most abundant cell 
component of the stroma and fibroblasts are known for their function in promoting 
tissue survival, remodeling and deposition of matrix components as well as production 
of extracellular matrix and structural support of the cells in the tissue [87, 88]. In 
addition to their important functions in remodelling and deposition of the ECM, they 
also play a key role in the formation and maintenance of epithelial musosa and 
submucosa including epithelial proliferation and differentiation [89]. Fibroblasts also 
actively interact with the adjacent epithelial layer and have a key role in tissue 
inflammation and repair [90].  
In immunology, fibroblasts have been recognized as important cells in the regulation 
of immune responses as well as supporting hematopoiesis [12, 91]. It should also be 
mentioned that, although, fibroblasts are the major stromal cells [11], also endothelial 
cells and tissue specific macrophages sometimes are referred to as stromal cells 
depending on their functional capacities related to hematopoiesis [92-94].  
 
2.2.2 Stromal cells support hematopoietic cell differentiation 
Hematopoiesis is dependent on specific niches in the microenvironment [95], which 
supports hematopoietic stem and progenitor cell (HSPC) survival and proliferation, by 
providing, specific cytokines, chemokines and adhesion molecules. There is evidence 
demonstrates that stromal cells in hematopoietic niches such as the bone marrow, fetal 
liver and spleen, produce extracellular matrix and form supportive structures, for 
proliferation and differentiation of HSPC [11]. In adults, bone marrow with its stromal 
cell components is the primary organ that supports HSPC homing, migration, survival 
and differentiation [2]. The regulation of hematopoietic cell homing and migration in 
bone marrow involves stromal cell-derived chemokines [96, 97]. For example, the 
chemokine CXCL12 is highly expressed by bone marrow stromal cells and act as 
chemoattractant (homing) for HSPC [98]. Under homeostatic conditions, HSPC in the 
bone marrow have been shown to be highly migratory and recirculate constantly 
between bone marrow and blood [99]. During inflammation or stimulation with 
cytokines such as CSF-2 and CSF-3, the blood HSPC numbers are altered [100, 101]. 
Except their migration between bone marrow and blood, HSPC have also been found in 
liver, spleen and muscles where they can proliferate and give rise to tissue-resident 
myeloid cells, preferentially DC [99]. During chronic inflammation or infection such as 
malaria, leishmaniasis and tuberculosis, there are disturbances in the hematopoietic 
compartment. For example, during the course of L. donovani infection myeloid 
progenitor cells have been shown to mobilize from the bone marrow into the circulation 
followed by increased hematopoietic activity in the spleen and bone marrow [102]. In 
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addition, splenic stromal cells from mice infected with L. donovani are altered and 
support the development of regulatory DC more efficiently compared to splenic stromal 
cells from non-infected mice  [12].  
Up to the present time the role of stromal cells in immunology has mostly been 
studied in lymphoid organ formation and haematopoiesis, while the role of peripheral 
tissue stromal cells in regulating hematopoietic cell function has largely been ignored.  
 
2.2.3 Tissue-specific cell regulation of dendritic cell function  
Within peripheral tissues, DC are embedded in ECM and are surrounded by fibroblasts 
and epithelial cells that play a key role in the regulation of DC differentiation and 
function [11]. In lung tissue, DC are in close contact with the respiratory epithelium 
and together they serve as the first line of defence against inhaled antigen [3, 103]. A 
rich body of literature suggests that lung tissue homeostasis and immune activation 
against inhaled antigen depend on the interplay between airway epithelial cells and DC 
[3, 104, 105]. For example, airway epithelial cells have been shown to express TLRs 
and can respond to microbial products [106-108]. Ligation of TLRs by epithelial cells 
leads to upregulation of pro-inflammatory mediators such as IL-6, IL-8, TNF-α, CSF-2, 
thymic stromal lymphopoietin (TSLP) and chemokines, which can regulate the 
function of DC [3, 109, 110]. In addition, dysfunction of TLR-expression in airway 
epithelial cells leads to altered immune activation of DC [104]. The cytokine TSLP 
produced by keratinocytes, lung epithelial cells and fibroblasts is a potent regulator of 
DC and can when aberrantly expressed induce activation of DC, which leads to 
induction of Th2-mediated allergic immune responses [111, 112]. Furthermore, DC 
trafficking in the lung has been shown to be regulated by the chemokines CCL2 and 
CCL20 secreted by fibroblasts [4]. It has also been recognized in cases of cancer that 
DC are strongly influenced by the local tumour microenvironment that can shape the 
phenotype and function of DC. 
 
2.2.4 Dendritic cell responses in the tumour tissue microenvironment 
It has become evident that the tissue microenvironment plays an important role in the 
promotion of tumour growth [113]. In addition, there is increasing evidence that 
immunological abnormalities are thriving in the tumour microenvironment. For 
example it has been shown that cancer cells inhibit immune-stimulating molecules, 
such as co-stimulatory molecules and cytokines in the local tumour microenvironment 
[114, 115], which may lead to the generation of regulatory DC and T cells [116, 117]. 
The tumour microenvironment is likely to produce chemokines that attract DC to the 
tumour area. The attraction of leukocytes to the tumour microenvironment could 
resemble the situation during wound healing [118]. These infiltrating leukocytes 
contain myeloid cells, such as neutrophils, DC, macrophages, eosinophils and mast 
cells as well as lymphocytes [119]. Leukocytes that are recruited to the wound are 
attracted by the local production of chemokines, cytokines and growth factors as well 
as necrotic products from tissue breakdown. Within this pathological site, leucocytes 
participate in the healing processes that include epithelial cell proliferation and 
migration, angiogenesis and tissue remodeling [120]. In tumours, similar 
chemoattractive factors are suggested to mediate the recruitment of leukocytes that 
may mediate comparable roles to those observed during wound healing. However, the 
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tumour cells continue to proliferate and attract leucocytes that could support the 
tumour progression [119]. This concept has led to the dogma of tumours as “wounds 
that never heal” [118]. As the tumour grow, the cells become less proliferative and 
more quiescent. In the center of the tumours, cell death and necrosis will occur, due 
to less accessibility of oxygen and glucose as well as increased accumulation of toxic 
metabolic products in the center of the tumour [121]. Dendritic cells play a crucial 
role in the induction of an effective immune response against tumours by engulfment 
of necrotic tumour cells and cross presentation of tumour antigen to initiate CD4+ and 
CD8+ T cells responses. However, in numerous types of cancers, tumor progression 
has been associated with a defective DC function that may be responsible for the 
failure of the immune system to fight against tumours [116]. Emerging evidence 
suggests that the tumour microenvironment alter the functional properties of DC and 
can convert them into potent immunosuppressive cells [122]. Therefore, an increased 
understanding of the underlying mechanisms that control DC function in the tumour 
microenvironment will provide important targets for intervention strategies in the 
clinical management of cancer. 
As the interaction and cooperation of DC with stromal cells, epithelial cells and 
other tissue-specific cells are increasingly appreciated as important components 
shaping DC heterogeneity and function, as well as maintaining tissue homeostasis and 
regulating inflammatory processes, it is important to further explore pathways of tissue-
specific regulation of DC. Technologies for studies of cell-cell interaction in 3D 
environments have been established but are often limited to animal models [123, 124]. 
Therefore, much of our knowledge on DC regulation by tissue-specific non-immune 
cells is limited to that generated in mice and less is known about tissue regulation of 
DC in humans. In addition, the disadvantage of using animal models is that many 
human pathogens induce species-specific responses, for example Mycobacterium 
tuberculosis, group A streptococcus and Staphylococcus aureus [125, 126]. The use of 
human tissue explants from epithelial tissues to study cell-cell interactions exists but is 
limited by the fact that they are difficult to maintain in culture and also the cellular 
composition of such organ cultures is difficult, if not impossible, to alter.  Therefore, 
there is an increasing need to develop in vitro 3D tissue models that are based on 
human cells. Those model systems provide unique tools for the exploration of 
biological processes in human tissue as well as basic mechanisms and early events 
important for the progression of human diseases associated to specific tissues. 
 
 
2.3 THREE-DIMENSIONAL TISSUE MODEL SYSTEMS 
Most of our knowledge of biological processes and cellular functions are based on 
results from studies of two-dimensional (2D) cell cultures, where most often one type 
of cell is grown, at a time on a plastic surface. Monolayer cultures have provided 
understanding of individual cellular responses but may not capture the physiological 
behaviour of cells in vivo [127-129]. Therefore, moving towards culturing cell in a 3D 
microenvironment that mimics the morphological and functional features of the in vivo 
human tissue is of utmost interest. Three-dimensional tissue models, also called 
organotypic cultures, involve cell culture techniques where the cells grow in a 3D 
environment that comprises the complex network of cells and ECM as well as other 
important biological molecules found in living tissues [130-132]. The main advantage 
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of using an in vitro tissue model is that the model is created from scratch with different 
combinations of cells that are cultured together into a multicellular assembly. In 
contrast to the tissue explants, cellular components of the 3D tissue culture can be 
manipulated, and genes can be silenced or overexpressed before included in the 
models. It also allows studies over time and can capture early events important for the 
regulation of hematopoietic cells by tissue specific cells, investigating the 
characteristics of immune responses upon stimulation with inflammatory reagents or 
interventions with pharmaceutical compounds. Mimicking a physiological relevant 
milieu, in a robust and reproducible manner can quickly provide important information 
on how immunological processes are regulated in tissue. Thus, human 3D tissue 
models provide an important and relevant tool to perform studies exploring immune 
regulation in health and disease. 
 
2.3.1 Scaffolds used in the three-dimensional tissue models  
There are some challenges to culture cells in vitro to fully mimic their in vivo parental 
tissue with the complex network of the ECM and cellular components present in vivo. 
To generate a 3D-culture, cells need to grow in a structure that mimics the ECM and 
support production of other biological molecules found in living tissues [84]. The 
generation of a 3D-culture starts with a suspension of cells in a liquid ECM solution, 
which then solidifies in a hydrated manner. The ECM scaffold should be porous to 
enable nutrient and metabolite exchange, and possess sufficient mechanical and 
biological properties to be self-supporting [84]. There are several commercial natural 
ECM components available such as Matrigel, type I collagen and fibrin gels. Among 
these, bovine type I collagen is perhaps the most widely used biologic scaffold due to 
that it is readily available and have been successfully used in many studies [133]. Also, 
type I collagen is the main structural protein in mammalian tissue and exhibits high 
mechanical strength and low biodegradability through cross-linking with other 
molecules [133, 134]. Even though, type I collagen does not supply all necessary 
components that exist in the ECM in vivo, it could still provide the initial framework 
that is needed for the generation of a relevant structural network that can be built up by 
the cells present, forming a more physiological relevant milieu. It has been shown that 
tissue specific cells secrete their own ECM, which can be incorporated into the local 
microenvironment. For example, Schwann cells in collagen gels express integrins when 
treated with TGF-β to promote their spreading and orientation [135]. 
 
2.3.2 Existing three-dimensional culture systems   
Various cell culture systems for studying host-pathogen interaction are used, 
including the use of monolayer systems based on one cell type that is cultured in the 
absence of extracellular matrix and other cellular components [136]. Alternatively, 
Transwell systems to culture cells on a permeable membrane that allow cells to 
develop an apical basal polarity are used [137]. The disadvantage of these methods is 
the lack of multicellular components and the complex 3D cellular interactions, which 
are crucial for normal tissue function, and will influence infection processes [128]. 
Yet, another approach is the use of a rotating wall vessel to generate 3D tissue 
structures using porous beads coated with collagen and basement membrane to 
culture epithelial cells [132]. These systems are also based on one type of cells and 
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lack the fibroblast components which is essential regulating several aspects of normal 
tissue function [89]. Engineering of 3D tissue models of skin [138], oral [139] and 
lung [140], which include a fibroblast extracellular matrix and a differentiated 
epithelial cell layer have been established. However, tissue models with relevant 
features and functions that include immune cells are rare. Combining 3D tissue 
models with immune cells would allow analysis of immunological responses in live 
tissue and increase our understanding of tissue regulation on function and behaviour. A 
skin tissue model containing DC has been developed [141, 142], however when we 
started this thesis work there was no tissue models available with relevant features 
and functions of human lung tissue, that included human immune cells.  
Overall, 3D tissue models provide powerful tools for the studies of host-pathogen 
interactions, the onset and progression of human diseases as well as for screening 
purposes of new drugs before being used in clinical trials. 
 
 
2.4 CHEMOKINES  
2.4.1 Role and classification of chemokines 
The proper interaction and communication between immune cells and tissue-specific 
cells locally are likely to be crucial balancing production of cytokines and chemokines 
at steady state and during inflammation. Chemokines are small (around 8-14 kDa) 
cytokines that regulate cell survival, activation and migration [98, 143, 144]. They play 
a central role in the orchestration of tissue homeostasis and inflammation, and their 
deregulated production have been implicated in several human infectious, 
inflammatory and autoimmune diseases such as viral infections [145, 146], atopic 
asthma [147], rheumatoid arthritis [148] and multiple sclerosis [149]. The work of this 
thesis has therefore focused on studying chemokine production and cellular migratory 
behaviour in the tissue microenvironment. 
Chemokines regulate cellular migration and can be divided into four subfamilies 
based on their cysteine residues: CXC, CC, C and CX3C chemokines [150, 151]. 
Chemokines act through seven-transmembrane domain G protein-coupled receptors 
abundantly expressed on leukocytes. More than 40 chemokines and 20 chemokine 
receptors have been identified in humans [152] (Table 2). In immunology, chemokines 
have fundamental roles in host defence mechanisms, immune homeostasis, immune 
regulation and hematopoiesis [153]. In addition to their significant functions in the 
immune system, chemokines play a major role in the regulation of embryogenesis, 
wound healing and angiogenesis [154]. Chemokines exert vital roles in all facets of the 
immune system and biological processes and almost all cells and tissues of the body 
have the ability to express chemokines. 
The capability of cells to migrate from the blood into the tissue, their location within 
tissue and interaction with other cells is dependent on chemokines. They are important 
promoting migration of for example neutrophils, monocytes, DC, lymphocytes and 
eosinophils [144, 155, 156]. It has become evident that chemokines regulate cell 
movement and localization during both homeostatic and inflammatory conditions. 
Based on this chemokines sometimes are categorized as constitutive or inflammatory 
[157, 158]. Under homeostatic conditions, chemokines are expressed constitutively at 
tissue specific sites such as thymus and secondary lymphoid organs. Their main 
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function under normal conditions is to regulate movement, homing and survival of cells 
and promote for example trafficking of lymphocytes and DC into lymphoid tissues 
[159-161]. In response to pathogenic stimuli, chemokine expression is induced or 
altered to promote the recruitment of effector immune cells to the site of inflammation 
and infection [162, 163]. 
 
2.4.2 Function of chemokines and their receptors 
The trafficking of leukocytes from blood into tissue is mediated by multiple signals 
generated from chemokines and their receptors [164]. Those highly regulated signals 
are essential for leukocytes to recognize and bind to the endothelium. The binding of 
leukocytes allows them to roll on epithelium into arrest and find a suitable locus to 
extravasate into the tissue [164]. Chemokine receptors have important functions both 
during inflammation and homeostasis. For example, the chemokine receptors such as 
CCR2 and CXCR2 are crucial for responses to a wide range of infectious and 
inflammatory challenges [165], while chemokine receptors such as CCR7 and CXCR5 
have been shown to have a central role in lymphoid tissue development as well as 
lymphocyte homing to lymph nodes during steady state [166, 167]. There is a group of 
chemokine receptors that do not signal via the G-protein coupled receptor pathway. 
These receptors share similar structure with the classical receptors but are referred as 
non-signalling chemokine receptors. The best characterized receptors in this family are 
DARC and D6 that are believed to have main function as scavenger receptors to bind 
and internalize chemokines for degradation [168]. DARC, however, has not only 
scavenger function but is also expressed on endothelial cells to support leukocytes 
recruitment into tissue during inflammation. This suggests that these atypical receptors 
play an important role in inflammation by removal of excess chemokines that could 
mediate tissue pathology and also orchestrate leukocyte entry into tissue in response to 
pathogens [168].    
 
2.4.3 Chemokines and dendritic cells 
The life cycle of DC is believed to include migration of DC precursor from blood into 
peripheral tissues where DC precursors differentiate into a stage of immature DC. In 
response to infection DC mature and alter their chemokine receptor repertoire allowing 
migration to the draining lymph nodes where DC induce T cell responses. Based on this 
knowledge, chemokines are considered to have a key role during DC development and 
function [169]. Several chemokine receptors are expressed selectively on the surface of 
DC and one of the major functions of chemokines is to navigate DC from the periphery 
to the secondary lymphoid organs both during steady state and in response to infection 
[164]. Upon antigen recognition, DC mature and express CCR7 [170] which make 
them responsive to CCL19 and CCL21. CCR7 and its chemokine ligands are crucial 
components in the migration of DC to the draining lymph nodes [171, 172]. In contrast, 
immature DC express CCR1, CCR5 and CXCR2 that make them responsive to CCL3, 
CCL5 and CXCL8, which are produced by tissue macrophages upon infection. 
Expression of those chemokines will recruit DC to the site of infection [173-175]. It has 
been suggested that migration of DC precursors and mature DC from blood into 
peripheral tissue in response to infection is regulated by CCR2 and its ligand CCL2 
[165, 176, 177].  
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Table 2. Schematic representation of chemokines and their receptor superfamily. 
Chemokines that have been shown to be induced upon inflammation and considered 
”inflammatory” are highlighted in red. Chemokines that are expressed under steady state 
conditions and considered ”constitutive” are highlighted in blue and those that have been 
observed to display both of the functions, constitutive/inflammatory, are shown in green. 
The ”atypical” receptor family is not included in this figure. 
 
Table 2. Chemokines and their receptors divided in either constitutive or 
inflammatory based on the chemokine expression 
Receptor Ligand(s) 
 
CXCR1 
CXCR2  
 
CXCL8, CXCL6 
CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, CXCL8 
CXCR3A 
CXCR3B 
CXCL9, CXCL10, CXCL11 
CXCL9, CXCL10, CXCL11, CXCL4 
CXCR4 
CXCR5 
CXCR6 
CXCR7 
CCR1 
CXCL12 
CXCL13 
CXCL16 
CXCL12, CXCL11 
CCL3, CCL3L1, CCL5, CCL7, CCL14, CCL15, CCL16 
CCR2  
CCR3 
CCR4 
CCR5 
CCR6 
CCR7  
CCR8 
CCR9 
CCR10 
CCR11 
XCR1  
CX3CR1 
Unknown  
 
CCL2, CCL7, CCL8, CCL13, CCL16 
CCL5, CCL7, CCL11, CCL13, CCL28, CCL3L1, CCL15 
CCL17, CCL22 
CCL3, CCL4, CCL5, CCL3L1, CCL4L1, CCL16 
CCL20 
CCL19, CCL21 
CCL1 
CCL25 
CCL27, CCL28 
CCL25 
XCL1, XCL2 
CX3CL1 
CXCL14, CXCL17, CCL18 
 
 
 
 
 
 
 
 
 
DC precursors have also been shown to express CXCR4 and respond to its ligand 
CXCL12, which suggests involvement of this chemokine for the entry of DC precursor 
into tissue [178]. 
It has also become evident that DC are producers of several chemokines. Immature 
DC can express a wide range of chemokines upon stimulation in tissue. this includes 
inflammatory chemokines such as CXCL8, CXCL10, CCL3, CCL4 and CCL5, which 
are believed to enhance the recruitment of neutrophils and monocytes to the infection 
site [179-181]. Other chemokines that are produced by DC under homeostatic 
conditions in specific tissues, include for example, the chemokine CCL17/TARC [182], 
CCL18/PARC [183, 184], CCL22/MDC [185], CCL25 [186] and CCL19 [187]. 
CCL18 is constitutively and highly expressed in peripheral tissue (i.e., lung) but at 
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lower levels in lymphoid tissues such as thymus and lymph nodes [184]. Monocytes, 
macrophages and DC are the main producers of CCL18 and CCL18 production by DC 
acts on the recruitment of naive T cells [183, 184] and immature DC [188]. In addition, 
CCL18 can attract Th2 cells, basophils [189] and skin-homing memory T cells [190]. 
This suggests that CCL18 is involved in both primary and secondary immune 
responses. Mostly CCL18 has been associated with anti-inflammatory or Th2 immune 
responses as it is induced by IL-10, IL-4 and IL-13 and downregulated by IFN-γ [188, 
191]. In addition, overexpression of CCL18 has been associated with allergic diseases 
such as atopic dermatitis [190, 192], rheumatoid arthritis [193] and asthma [189]. 
Recently, CCL18 has also been shown to support differentiation of regulatory T cells 
from CD4+ memory T cells [194] as well as to differentiate DC into tolerogenic cells 
[195]. There is no CCL18 homologue in rodents [196] and as of yet no CCL18 receptor 
has been identified.  
The chemokines CCL17 and CCL22 are highly expressed in thymus but are weakly 
expressed in peripheral tissues such as lung, spleen, colon and intestine under steady 
state conditions [182, 185]. In contrast, both CCL17 and CCL22 are more easily 
detected in inflamed peripheral tissue and therefore considered inflammatory 
chemokines. Mainly myeloid cells including macrophages and monocyte-derived DC 
express these two chemokines [182, 185] that signal through the receptor, CCR4. 
CCL22 attracts DC, NK-cells and monocytes, while CCL17 attracts mainly T 
lymphocytes. Studies have suggested that CCR4 is associated with a Th2 type immune 
response [197]. In addition, high levels of CCL17 and CCL22 are associated with 
allergic diseases such as pulmonary fibrosis [198] and asthma [199].  
Given the strategic positions of DC in most tissue and their importance in 
orchestrating immune responses locally [3, 200], interfering with DC is therefore 
thought to provide an important strategy in the clinical management of several human 
diseases. However, most studies of DC biology have been performed in 2D cultures on 
plastic surfaces or in mouse experimental models, which may not capture many 
important aspects of human DC behaviour. Therefore, there is an increased demand for 
the development of new approaches allowing the exploration of human DC in more 
physiological relevant milieus. Thus, organotypic models, we believe, provide good 
tools recapitulating the 3D structures of human tissue where DC normally act. Using 
such 3D tissue models will allow modelling of immunological responses that occur in 
human tissue, under next to in vivo setting. 
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3 STUDY DESIGN 
In this chapter I have summarized the hypotheses and methods, which are the basis for 
this thesis. The first section focuses on the experimental set up of the lung tissue model 
with DC and the second section focuses on how the experiments on HSPC regulation 
by stromal cells were performed.  
 
 
3.1 THE ORGANOTYPIC LUNG TISSUE MODEL PROJECTS 
The majority of DC subsets are derived from the bone marrow and a common 
hematopoietic progenitor cell that proceed into precursor DC seeding the blood. In 
blood precursor DC are considered brief transients that traffic to peripheral organs and 
tissue [30]. The local tissue microenvironment further supports differentiation of 
precursor DC into different DC subsets, thereby contributing to DC heterogeneity [13].  
Emerging evidence also indicates that DC residing in tissue receive instructions from 
ECM components and non-immune cells of the tissue, i.e. fibroblasts and epithelial 
cells, shaping their phenotype and function locally and this is believed to be essential 
for the maintenance of tissue homeostasis and the regulation of local immune responses 
[12, 82, 104]. In this respect, we believe that reductionist approaches, in which only 
one or a couple of cellular components are studied at a time, are generally, insufficient 
and sometimes misleading. Instead, experimental designs owes to move towards a 
more comprehensive and quantitative understanding of how the countless interrelated 
components form networks that exert a particular function, including shaping DC 
functions in tissue. Hence, in vitro human organotypic tissue models combining DC 
with tissue-specific cells can be useful tools to capture molecular events that determine 
DC functions as well as to provide a potential bridge between human cell-based 
research and patient studies (Figure 4). Therefore, we have been focusing on the 
development of a tissue model of human lung mucosa combining DC with fibroblasts 
and epithelial cells cultured in a 3D microenvironment. The use of in vitro tissue 
models will contribute to the increase of our knowledge in mechanisms regulating 
tissue immune responses under homeostasis and during inflammation. 
 
3.1.1 Our hypotheses  
Local tissue microenvironments, such as lung, gut and intestine are recognized to 
regulate DC differentiation and function. Therefore, we first hypothesized that 
implanting DC into an organotypic model of human lung, composed of lung fibroblasts 
and epithelial cells, should impact on DC function mimicking real tissue.  
In lung tissue, DC and epithelial cells are the first cells to encounter inhaled antigens 
and they are well equipped with pattern recognition receptors such as TLRs. By 
responding to TLRs they orchestrate the outcome of immune responses to pathogens. 
Therefore, in the second study we hypothesised that stimulation of the lung tissue 
model with TLR-ligands or chemokine should induce DC migration that can be 
monitored in real time.  
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In the third study, we hypothesized that the tumour microenvironment in lung tissue 
will have the capacity to modulate DC functional properties promoting immunological 
abnormalities thriving in lung cancer. 
 
 
 
 
 
3.1.2 Experimental design to test our hypotheses 
The studies in this thesis are based on advanced cell culture techniques with different 
human cell populations to create a 3D tissue model system, which resembles the tissue 
microenvironment in vivo. To test our hypotheses, I developed a 3D lung tissue model 
with DC. To answer the question if the microenvironment in this model has the ability 
to influence DC function mimicking real lung tissue, I investigated if this model can 
support DC survival without addition of exogenous growth factors and how the lung 
tissue model influences chemokine expression by DC under homeostatic condition. To 
test if DC in the tissue model respond to TLR-ligands and chemokine, I first established 
a lung tissue model with fluorescent expressing cells and then used quantitative 4D (x, 
y, z, time) fluorescence imaging analyses to monitor DC migration in the tissue model 
in response to stimulation. To investigate if DC function is influenced by the tumour 
microenvironment in lung tissue, we further developed the 3D lung tissue model with 
DC and incorporated epithelial tumour spheroids, mimicking micro-tumours in tissue. 
We then investigated if DC were recruited to the tumour area in the tissue model and if 
DC engulf tumour cells more readily than “normal” cells. In the following sections I 
will give a description of the design and set up of the lung tissue model and thereafter I 
will describe the research methods that were used to apply our experimental design.  
Figure 4. This illustration places the 3D human tissue model as a potential bridge between human cell-
based research and patient studies.  
 
Figure 4 
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3.1.3 Design and set up of human lung tissue model with dendritic cells 
3.1.3.1 The choice of cells for the model set up 
To generate a highly reproducible tissue model system, we choose to use MRC-5 lung 
fibroblasts, 16HBE14o- (16HBE) lung epithelial cells and human monocyte-derived 
DC. MRC-5 is a primary cell line derived from normal lung tissue of a 14-week-old 
male fetus [201]. It is relatively easy to culture and can be passaged up to 42 to 46 
times before senescence. The epithelial cell line 16HBE14o- originates from primary 
bronchial epithelial cells immortalized with the large SV40 T-antigen. The 16HBE cell 
culture exhibits similar characteristics as primary epithelial cells by maintaining 
essential transport mechanisms as well as expression of tight junctions and structures 
resembling cilia. To culture the 16HBE cells we pre-coat tissue culture flasks with 
fibronectin, which promote the cells to maintain their original differentiated phenotype 
[202]. Dendritic cells used in the tissue model were generated from human blood 
monocytes cultured in CSF-2 and IL-4. As mentioned in the background chapter, 
MoDC have been widely used as a model system for studying human DC because they 
are readily accessible and can be generated in large numbers. The in vitro generated 
MoDC are thought to resemble the DC that are differentiated from monocytes in vivo 
primarly during inflammation [80, 203, 204].  
 
3.1.3.2 The set up of a functional three-dimensional tissue culture 
To culture the tissue model, I used a Transwell system where the tissue model is grown 
on a permeable membrane with a pore size of 3 µm in a six-well insert. During air-
exposure the cells in the model receive nutrition from the medium in the outer chamber, 
therefore, it is important to have a relatively large pore size of the insert membrane in 
order to obtain an optimal diffusion of the medium. I have also tried with a pore size of 
0.45 µm, but then models did not grow appropriately, which may depend on 
insufficient diffusion of nutritions. Also, six-well inserts have an appropriate size to use 
for practical reasons, but smaller inserts may be used. 
A crucial component in the development of 3D tissue cultures is the scaffold that 
supports the cells in the model. In this setting, I have used bovine type I collagen from 
Organogenesis which provides a good and reproducible collagen matrix [139]. To 
create, in vitro, a functional microenvironment, MRC-5 fibroblasts were mixed and 
cultured in bovine type I collagen for seven days in the inserts. During this time, the 
fibroblasts reorganized and contracted the collagen matrix to form the structural 
framework, the basis, of the tissue model [83]. The next cellular component implanted 
was the DC, which were generated from human blood monocytes cultured in CSF-2 
and IL-4 for six days before being implanted into the model. Dendritic cells were 
seeded onto the fibroblast matrix before seeding of epithelial cells, which were then 
seeded onto the DC-fibroblast matrix. After epithelial cells had formed a confluent 
layer, the culture was air exposed (Figure 5). The air-exposure is important for the 
epithelial cells to form a stratified and polarized multilayer that recapitulates the in vivo 
epithelial barrier architecture [83]. The culture procedure takes approximately 16-20 
days including the time of air-exposure, which usually is for 4-7 days.  
 
 
 
  24 
 
 
 
 
 
3.1.4 Selection of research methods  
I have used several research methods to analyse cellular responses in the tissue model. 
These methods include immunohistological analysis of the tissue model using 
immunohistochemistry and immunofluorescence staining of tissue sections, as well as 
performing RNA analysis using real time QRT-PCR, protein analysis using ELISA and 
collagenase digestion of the tissue model to isolate cells for flow cytometric analysis. In 
addition, one key method in this study has involved assessment of DC migratory 
behaviour in the tissue model using quantitative fluorescence live imaging microscopy.  
In the following sections, I will give a brief description of the methods used. I 
distinguish between methods that require “invasive” techniques for analysis of the lung 
tissue models, such as sectioning, lysis of the model for RNA extraction and 
collagenase digestion, and those that are “non-invasive” techniques, which include live 
cell imaging of the models.  
 
3.1.4.1 “Invasive” methods    
After completion of the lung tissue model set up, models were removed from the 
culture inserts and either frozen for cryostat sectioning or lysed directly for mRNA 
analysis. The supernatant in the outer chamber can be collected for protein analysis. 
Models can also be digested using collagenase and the cells recovered can be used for 
flow cytometric analysis.  
 
Figure 5. This illustration depicts a complete 3D lung tissue model of fibroblasts in collagen matrix and 
DC that are located close to the stratified epithelial layer. The model is cultured under air-exposure on a 
permeable membrane and receives nutrition through diffusion of the medium from beneath.  
 
Figure 5 
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Cryostat sectioning of the lung tissue model  
To visualize the structure of the 3D lung tissue model, cryostat sectioning of the model 
was performed following hematoxylin and eosin staining of the tissue sections. 
Sectioning of the lung tissue model can be difficult, because the model is very thin 
(approximately 500 µm) and fragile. To obtain optimal sectioning conditions, the 
model was treated in 2M sucrose for one hour following snap freezing in liquid 
nitrogen and storage in -80 °C until sectioned. Models were sectioned with a thickness 
of 8 µm/section, which we have experienced being an optimal thickness for 
immunohistological stainings. The sections were then fixed in either icecold acetone for 
2 minutes or paraformaldehyde for 12 minutes, dependent on the antibodies used in the 
staining. The fixed sections can be stored in PBS in 4 degree for up to one week, but 
staining directly after sectioning is preferred for reproducibility reasons. After the first 
sections were cut I always checked that model structures were properly formed using 
hematoxylin staining.  
 
Immunohistochemistry and computerized image analysis   
Immunohistochemistry (IHC) staining was used to visualize tissue morphology and cell 
distribution in the lung tissue model. In this method, specific antibodies are used to 
detect antigens in tissue sections [205]. The antigen-antibody binding can be 
demonstrated with a colored histochemical reaction that is visible by light microscopy 
[206]. This method provides a powerful detection technique to examine protein 
expression within cells or tissue. In addition, I have used immunohistochemistry in 
combination with computerized image analysis to analyse DC marker expression in the 
tissue model. Computerized image analysis enables semi-quantitative analysis of 
protein expression at the single cell level in cryopreserved tissue. This analysis uses a 
highly sensitive computerized analysis software (Leica Qwin) that can distinguish 
between a wide range of colours and provide a detailed assessment of different 
proteins. Analysis of positive immunostaining was performed by transferring digital 
images of the stained tissue, acquired by a light microscopy, to a computerized 
Quantimet 5501W image analyzer [207]. Single-positive stained cells were quantified 
in 25 high-power fields, and protein expression was determined as the percent 
positive area of the total relevant cell area using the Qwin 550 software program 
(Leica Imaging Systems). The total cell area was defined as the nucleated and 
cytoplasmic area within the tissue. Tissue sections stained with secondary antibodies 
only were used as negative controls. This technique is well established in our 
laboratory and has been widely used to study expression of different proteins in 
human as well as in animal tissues. 
 
Immunofluorescence analysis  
Immunofluorescence was used to characterize structural proteins and cellular markers 
in the tissue model. This method is complementary to the immunohistochemistry 
analyses as it enables visualization of several proteins and colocalization of proteins in 
the same section. This technique uses specific antibodies as for IHC to bind antigens in 
the cells or the tissue. Secondary antibodies direct conjugated with different fluorescent 
dyes of choice were used to detect the primary antibody binding. The fluorescent dyes 
were then visualized with fluorescence or confocal microscopy. 
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Real time reverse transcription polymerase chain reaction, RT-PCR 
This method provides a sensitive and powerful tool for analysing RNA that compares 
the relative transcriptional abundance in tissue and cells. For comparison of gene 
expression between different samples, I used the mRNA analysis as complement to the 
protein analysis and also as a screening method to investigate multiple markers before 
analysing protein expression of interest. The method is based on quantitative 
measurement of the amplified DNA using fluorescent probes. The RNA is first 
converted to complementary DNA using a reverse transcriptase and the DNA is used as 
a template for amplification using PCR. This method gives the most sensitive detection 
of RNA and can detect transcript of principally any genes [208, 209]. In this study, I 
used relative RT-PCR to compare gene expression between different samples. For this 
purpose, an internal control that was not effected by the experimental treatment, was 
monitored in the cells at the same time as the gene of interest and was used to 
normalize the samples. Relative amounts of the gene of interest were calculated using 
the comparative threshold cycle method [210]. The threshold correlates to the cycle 
number where there is sufficient amplified product to give a detectable reading, and, 
if the threshold is not attained after 35–40 cycles, the mRNA is considered 
undetectable.  
 
Enzyme-linked immunosorbent assay, ELISA 
To identify proteins secreted from the 3D tissue models and single cell culture, ELISA 
was used. ELISA provides a highly sensitive quantitative measurement of protein 
levels in culture supernatants, and is based on the use of capture and detection antibody 
pairs that bind specifically to the protein of interest in the supernatant forming a 
“sandwich” complex with the antigen. The detection antibody is then linked to an 
enzyme that is developed by adding an enzymatic substrate to produce a colour change 
that can be measured using a spectrophotometer [211, 212].   
 
Collagenase digestion and flow cytometry 
Collagenase digestion has enabled extraction of the cellular components from the tissue 
model and following extraction the cells were stained with fluorescently conjugated 
antibodies directed against specific surface markers. To analyse surface marker 
expression, flow cytometry was used. This method allows us to characterize the 
different cell types in the tissue model based on their expression of specific cell surface 
markers, size, and granularity. Flow cytometry is a useful method for qualitative 
measurement of cell surface marker expression as well as protein expression in the cells 
[213, 214]. This technique is based on detection of the fluorescent-labelled cells that are 
passing through a laser beam, cell by cell.  
 
3.1.4.2 “Non-invasive” method - live cell imaging analysis  
Live cell imaging, we consider a “non-invasive” method that enables studies on cellular 
structures, localization of molecules and dynamic processes in real time. The technique 
also allows visualization and quantification of cell trafficking, enzyme activity and 
signal transduction as well as monitoring cellular processes within live tissue. In this 
thesis work, I have used live cell imaging to study DC migration in the tissue model 
stimulated with different inflammatory stimuli and chemokine. For this purpose, we 
have generated fluorescent fibroblasts (orange) and epithelial cells (GFP), using a 
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retroviral transduction system to obtain stable transduction of the cells. Dendritic cells 
as well as epithelial cells used for spheroid formation were labelled with a cell tracker 
dye before implanting into the model. Before live imaging experiments, models were 
stimulated with different stimuli and were then removed from the culture inserts and 
mounted onto a glass bottom culture six well plate suitable for live imaging. Then an 
inverted confocal microscope was used for live imaging of six models 
simultaneously. Models were imaged over a time period of 12-16 hours with 20 
minutes intervals and images were captured with a z-dimension of 120-150 um. The 
deep penetration of the laser into the models was possible due to the fact that the 
tissue models, we believe, are much more transparent than real tissue, which reduces 
the light scattering. 
The main critical aspect to consider during live cell imaging experiments is the 
maintenance of the conditions supporting cell survival and the well being of cells 
during acquisition. This requires keeping the temperature, pH and humidity in the 
microscope chamber constant. Other important aspects to consider include the choice 
of appropriate fluorophores, such that they should have low cytotoxicity and allow a 
minimum of laser exposure time. Also, physical vibrations should be kept at a 
minimum [215]. We used a confocal laser microscope system, A1R, from Nikon. The 
A1R has a resonant scanner system that allows ultra high-speed imaging and enables 
simultaneous photo-activation. This system enables us to image several models 
simultaneously using multi-colour imaging and a z projection of 150 mm at an interval 
of 20 minutes. In addition, we have equipped the instrument with an incubator that 
automatically control temperature, CO2 and humidity. Furthermore, the microscope is 
equipped with a feedback-controlled isolation table that is gas-filled to reduce room and 
building low-frequency vibrations. In our experiment, DC were labelled with a far red 
cell tracker dye that is excited using a long wavelength, which minimize phototoxicity 
for the cells.  
The analysis of the images collected requires the appropriate software. It should, 
preferably, be able to perform automatic data analysis and have the ability to handle 
large data sets. There are many software programs available, which are open source, 
such as Fiji and CellProfiler. Another powerful, but rather expensive, live imaging 
software is Imaris. Cost aside, it is one of the best, we believe, softwares for analysis of 
3D and 4D microscopy datasets. For data analysis of DC migration in the tissue model, 
we have chosen to use the Imaris software, because it can perform automatic tracking 
of the cells as well as handle large datasets and is user-friendly. 
 
 
3.2 STROMAL CELL-MEDIATED DEVELOPMENT OF REGULATORY 
DENDRITIC CELLS 
The hematopoietic nische, such as the bone marrow, spleen and fetal liver, in which 
HSPC and stromal cells are situated, have been shown to exert strong influence on the 
migration, homing, survival and differentiation of HSPC [2]. Homing and migration of 
HSPC involves chemokines derived from the stromal cells in the hematopoietic 
microenvironment [216, 217].  
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3.2.1 Our hypotheses 
There is evidence that during L. donovani infection, a rapid mobilization of HSPC into 
the blood circulation occur. In addition, HSPC are dramatically increased in the spleen 
and bone marrow of infected mice [102]. Furthermore, studies have shown that splenic 
stromal cells support the differentiation of HSPC into regulatory DC and this ability is 
enhanced during L. donovani infection [12, 13]. However, in the latter study it was not 
shown if the enhanced effect to support HSPC differentiation depended on direct 
infection of the stromal cells or on the inflammation that occurred during infection. 
Also, the specific stromal cell-derived factors that promote the differentiation of HSPC 
into regulatory DC at steady state and in chronic infection have not been identified. 
In this study, we first hypothesized that bone marrow stromal cells from mice could 
support HSPC differentiation into regulatory DC by the involvement of chemokines. . 
We then hypothesized that the direct infection of bone marrow stromal cells with L. 
donovani will alter their chemokine expression, which may lead to enhanced ability of 
the stroma to recruit HSPC and to support increased development of regulatory DC. 
 
3.2.2 Experimental design to test our hypotheses 
To test our hypotheses, we first used a murine bone marrow stromal cell line MBA-1 
[218] that was accessible, easy to culture and susceptible to L. donovani infection. For 
this purpose, MBA-1 cells were tested for their ability to recruit HSPC as well as 
supporting the differentiation of HSPC into regulatory DC both at steady state and 
during L. donovani infection. A macrophage cell line RAW264.7 that did not support 
hematopoiesis was used as negative control [218]. To analyse differences in gene 
expression of MBA-1 and RAW264.7 cells, we performed genome-wide analysis of 
mRNA expression in the cell lines in the presence and absence of infection. Based on 
the outcome of the genome-wide analysis, hypotheses were tested first in vitro using 
MBA-1 cells and second in vivo using a murine model of visceral leishmaniasis. 
3.2.3 Selection of research methods  
Immunofluorescence analysis 
We used immunofluorescence analysis to verify expression of surface markers on DC 
that differentiated from HSPC cultured on MBA-1 cells. Also, this method was used to 
visualize L. donovani infection in MBA-1 and RAW264.7 cells as well as chemokine 
expression by MBA-1 cells and in mouse splenic tissue.  
 
Flow cytometry 
This method was used to examine the different DC population that developed from 
HSPC cultured on MBA-1 cells as well as examine the number of HSPC that migrated 
during different culture conditions in a Transwell migration assay.  
 
Allogeneic Mixed leukocyte reaction 
This assay was used to investigate if DC derived from HSPC displayed regulatory 
properties by examining their ability to inhibit T cell proliferation induced by CSF-2-
derived LPS-stimulated DC. Mixed leukocyte reaction (MLR) is a reaction that occurs 
when leukocytes from two genetically differing individuals are cultured together [219]. 
Leukocytes in the culture will stimulate each other to proliferate and the proliferation 
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can be measured by tritiated thymidine uptake. In a one-way MLR test, one donor 
serves as responder and the other as stimulator. The stimulator cells (DC) are 
inactivated by radiation or by mitomycin C to allow only the responder cells (T cells) to 
proliferate in response to foreign histocompatibility antigens. In this way, this assay can 
measure the ability of DC to induce T cell proliferation. 
  
Transwell migration assay 
This assay was used to study the migratory response of HSPC towards MBA-1 cells. 
This assay is also known as the Boyden chamber assay [220]. The assay procedure was 
performed as follows: HSPC were placed on the permeable membrane in the upper 
chamber (insert) of a Transwell systems and the MBA-1 cells or culture supernatants 
from the MBA-1 cells were placed in the lower chamber. Following incubation (3-18 
hours), the cells that migrated through the membrane were stained and counted using 
flow cytometry. 
 
Microarray analysis 
This method was used to analyse gene expression profiling in MBA-1 cells and 
RAW264.7 cells by measure the expression of thousands of genes at once to provide an 
overall view of the transcriptional activity and to display the status of the cells in 
response to a particular treatment. This assay is based on hybridization of total mRNA 
to thousands of different synthetic oligonucleotides of define sequence and serve to 
probe the composition of the RNA content [221].  The oligonucleotides contain pairs of 
probes for each of the RNAs of interest. Before hybridization, fluorescently labelled 
ribonucleotides were incorporated into the target RNA following randomly fragmenting 
of the RNA that was hybridized to arrays. Fluorescence images, also called heat maps, 
of the array were obtained using a scanning confocal microscope that revealed data of 
individual values represented as colours, for example high gene expression was 
represented by red colour while lack of gene expression was represented by blue 
colour.   
 
Real time quantitative RT-PCR 
Since high throughput microarray lack the quantitative accuracy, we used real time 
QRT-PCR to validate and semi-quantify candidate chemokine genes of interest from 
the microarray analysis in MBA-1 cells and RAW264.7 cells, as well as splenic tissue. 
A more detailed description of the method can be found in section 3.1.4. 
 
Immunohistochemistry 
This method was used to investigate chemokine protein expression in splenic tissue of 
uninfected mice and mice infected with L. donovani.  A more detailed description of 
the method can be found section 3.1.4.  
 
Enzyme-linked immunosorbent assay, ELISA 
This assay was used to measure the protein levels of chemokines in the culture 
supernatants of splenic stromal cells isolated from uninfected and infected mice with L. 
donovani. A more detailed description of the method can be found section 3.1.4. 
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4 AIMS OF THE THESIS 
The overall aims of this thesis were to study tissue regulation of DC function, migration 
and chemokine production as well as stromal cell-derived chemokine regulation of 
regulatory DC development following L. donovani infection. The specific aims were:   
 
1. To establish a human organotypic model of human lung with DC and study DC 
survival and chemokine production in the tissue model under homeostatic 
conditions. 
 
2. To further develop the organotypic model for live imaging analysis and 
investigate DC migration in response to TLR-ligands and chemokine. 
 
3. To generate an organotypic-based epithelial spheroid model of human non-
small lung cancer and study DC interaction with cancer cells. 
 
4. To investigate the influence of stromal cell-derived chemokines on HSPC 
migration and differentiation into regulatory DC under steady state and in 
response to L. donovani infection.   
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5 THE RESULTS OBTAINED IN OUR STUDIES  
This chapter presents the results achieved in the thesis work. The first section describes 
the establishment of a 3D lung tissue model with DC and the examination of 
chemokine expression by DC in the lung tissue model. In the second section, the 
further development of the lung tissue model for live cell imaging analysis is described, 
as well as the investigation of DC migration in response to inflammatory stimuli in the 
tissue model. The third section focuses on the development of the lung tissue model to 
study DC interaction with tumor cells, and finally, the fourth section concentrates on 
how murine stromal cell-derived chemokines support the development of regulatory 
DC during homeostasis and in an experimental model of L. donovani infection.  
 
 
5.1 DEVELOPMENT OF A THREE-DIMENSIONAL TISSUE MODEL OF 
HUMAN LUNG MUCOSA WITH DENDRITIC CELLS 
Despite the many important progresses in the field of DC biology, little is known about 
the function of DC within the complex microenvironment of human tissue. To 
investigate DC function and behaviour in the lung microenvironment and to reveal 
pathways by which human DC interact with tissue-specific cells and may orchestrate 
lung tissue homeostasis and regulate immune responses against pathogens, we sought 
to develop a 3D tissue model of human lung mucosa. This model composes human DC 
embedded in a physiological microenvironment made of lung epithelial cells and lung 
fibroblasts, which produce extracellular proteins and proteins essential for epithelial 
barrier functions. 
 
5.1.1 Architecture and extracellular matrix composition of the model 
The human airway epithelial tissue comprises of a stratified epithelial layer supported 
by a basement membrane and an underlying extracellular stroma matrix layer 
containing extracellular matrix proteins, fibroblasts, lymphatic vessels and immune 
cells such as lymphocytes and DC. Our results from hematoxylin and eosin (H&E) 
histological analysis of the lung tissue model revealed a stratified and polarized 
structure of the epithelial cells lining an extracellular matrix layer of fibroblasts (Figure 
1D, paper I). Furthermore H&E staining of the tissue model indicated a basement 
membrane-like structure separating the epithelium from the fibroblast compartment 
(Figure 1D, paper I). Therefore, we investigated the expression of essential 
extracellular matrix proteins and proteins associated with basement membranes in the 
tissue model, such as tropoelastin, collagen IV and laminin-5. Immunofluorescence 
staining revealed expression of the ECM proteins by both epithelial cells and 
fibroblasts in the model. Deposition of these proteins by the cells in the model 
displayed a continuous basement membrane at the boundary between the epithelial 
layer and the underlying fibroblast matrix (Figure 2A, B and D, paper I). In addition, 
fibroblasts in the model were positively stained for vimentin, which is the major 
cytoskeletal component of fibroblasts and mesenchymal cells [222] (Figure 2C, paper 
I). Furthermore, epithelial cells in the model expressed and deposited tight and 
adherence junctional proteins, including E-cadherin, occludin and claudin (Figure 3A 
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and B, paper I), which have been shown to be essential for the formation of a 
functional epithelial cell barrier [223, 224]. These data revealed that our 3D lung tissue 
model comprises a fibroblast collagen matrix rich in extracellular matrix proteins and 
a tightly joined stratified epithelium on top of a continuous basement membrane. 
Thus, our 3D lung tissue model displays morphological and functional properties that 
mimic normal lung epithelial tissue (Figure 1E, paper I). 
 
5.1.2 Survival and distribution of dendritic cells in the lung tissue model 
DC are found throughout the airway mucosa and are strategically situated in close 
association with the epithelium where they act as sensors sampling antigens in the 
airway [3, 103]. Immunohistochemistry staining of HLA-DR on tissue model sections 
revealed that DC were located close to the epithelial layer (Figure A and B, paper I). 
To investigate whether or not DC survived equally well without growth factors, models 
were cultured either with or without CSF-2 and IL-4 for 11 days. Quantitative 
computerized image analysis of HLA-DR immunostaining indicated that DC survived 
equally well in models cultured with or without exogenous growth factors (Figure 4D, 
paper I). Although we observed that DC survived in the absence of exogenous growth 
factors, we were interested in knowing how well DC survived over time in the tissue 
model. For this purpose, DC were labelled with a far red cell tracker dye before being 
implanted into the model. Live confocal microscopy was used to monitor the quantity 
of DC over time. Images were captured at day 1, 3, 5, and 8 after implantation of DC 
into the tissue model (Figure 5A and B, paper I). The number of DC in each of the 
acquired confocal images was calculated and the results revealed a significant decrease 
in DC quantity at day 8 compared to day 1 (Figure 5C, paper I). Although, our data 
demonstrated that the lung tissue model support survival of DC in the absence of 
exogenous growth factors there was a loss of DC overtime.  
To further identify and investigate the location of DC in the lung tissue model, tissue 
sections were stained for well-defined DC markers such as HLR-DR, DC-SIGN and 
CD11c. The immunofluorescence staining revealed HLA-DR+ DC located within the 
epithelium (Figure 6A, paper I) and HLA-DR+DC-SIGN+ DC could be detected in the 
basolateral space beneath the epithelial layer (Figure 6B, paper I). Interestingly, we 
could also detect CD11c+DC-SIGN+ DC distributed on the apical side of the epithelium 
(Figure 6C, paper I). In lung tissue, it has been suggested that the chemokine CX3CL1, 
the ligand for CX3CR1, is important for DC interaction with the epithelial layer. 
CX3CL1 has been reported to be produced mainly by epithelial cells, whereas the 
receptor CX3CR1 expression is restricted to leukocytes [225]. To investigate the 
expression of CX3CL1 in the lung tissue model, we performed mRNA analysis of 
CX3CL1 expression in lung tissue model with and without DC and compared this to the 
expression of CX3CL1 in DC cultured in medium. Interestingly, the lung tissue model 
with DC showed the highest expression of CX3CL1 among the three conditions (Figure 
4E, paper I). In addition, immunofluorescence staining of CX3CL1 revealed that the 
chemokine is highly expressed by epithelial cells in the lung tissue model, (unpublished 
observation). Therefore we sought to confirm the expression of the CX3CL1 receptor, 
CX3CR1, in the lung tissue model. As shown in Figure 6D, paper I, 
immunofluorescence staining revealed CX3CR1 positive cells situated close to the 
epithelium in the lung tissue model. To prove that the CX3CR1 positive cells indeed are 
DC we will need to perform double staining and include DC specific markers. 
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In summary, DC in our lung tissue model are strategically located underneath, 
within, and at the apical side of the epithelium consistent with a previous report 
[226]. Furthermore, the model supports DC survival without exogenous growth factors 
for at least eleven days and DC survival can be monitored over time. Together, these 
results indicate that our 3D lung tissue model composed of human epithelial cells, 
fibroblasts and DC form a functional physiological microenvironment that recapitulates 
key anatomical and functional features of lung mucosal tissue.  
 
5.1.3 Regulation of dendritic cell chemokine producing capacities by the 
microenvironment 
To investigate whether our lung tissue model regulates chemokine production by DC 
under physiological conditions, we investigated the expression of CCL18, CCL17 and 
CCL22 mRNA and protein levels in the lung tissue model using real time QRT-PCR 
and ELISA. CCL18 is constitutively expressed in lungs, whereas CCL17 and CCL22 
have low expression in lungs under homeostatic conditions but can be induced upon 
inflammation. Interestingly, these analyses revealed that CCL18 was highly expressed 
in the tissue model with DC, both at mRNA and protein levels, compared to DC 
cultured in medium only. In contrast, lung tissue models without DC showed no 
expression of CCL18 (Figure 7A and B, paper I). In addition, low levels of CCL17 
and CCL22 mRNA and protein expression were detected in lung tissue models with 
and without DC compared to DC cultured in medium (Figure 7C and F, paper I). 
These data show that the lung tissue model has the ability to regulate chemokine 
production by DC, which involves enhanced expression of CCL18 and a reduced 
expression of CCL17 and CCL22. In order to investigate whether or not the induction 
of CCL18 production in DC depends on soluble factors secreted by the tissue model, 
DC were conditioned with supernatant from the lung tissue model. As shown in Figure 
8A and B, paper I, DC conditioned with supernatant from the lung tissue model had 
enhanced expression of CCL18 mRNA and CCL18 protein secretion compared to DC 
cultured in medium only. As secreted compounds from the lung tissue model regulated 
CCL18 induction in DC, we were interested investigating if this regulation was 
dependent on the composition of the epithelial cells and fibroblasts that were grown 
together under air-exposure in a 3D structure. DC were conditioned with supernatants 
from air-exposed epithelial cells, fibroblasts or a submerged mixed monolayer of 
epithelial cells and fibroblasts. The data from mRNA analysis revealed that only 
supernatant from the lung tissue model could robustly induce CCL18 production by DC 
compared to DC cultured in medium only (Figure 8C, paper I). These data indicate 
that only the complete lung tissue model is required to efficiently induce enhanced 
CCL18 expression in DC. 
In this study, we have developed a 3D human lung tissue model that comprises three 
parts: a stratified and polarized epithelium that is grown on top of a basement 
membrane, an underlying fibroblast matrix layer rich in extracellular matrix proteins as 
well as DC that are closely distributed to the epithelial layer. Our lung tissue model 
recapitulates the structure of normal lung mucosal tissue and is fully functional in the 
deposition of extracellular matrix proteins and production of tight and adherence 
junctions. Furthermore, the lung tissue model supports DC survival for at least eleven 
days without addition of exogenous growth factors and we could also observe that DC 
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production of the chemokines CCL17, CCL18 and CCL22 is regulated by the lung 
tissue microenvironment in ways resembling physiological conditions.  
 
 
5.2 THE LUNG TISSUE MODEL ENABLES LIVE IMAGING ANALYSIS OF 
HUMAN DENDRITIC CELLS IN A PHYSIOLOGICAL MILIEU 
In the previous section, we demonstrated the establishment of our 3D lung tissue model 
that allows studies of human DC in a physiological relevant milieu. Here, we 
demonstrate how this tissue model can be used for live imaging analysis of DC 
migratory behaviour in response to inflammatory stimuli and chemokine.  
Little is known about local tissue-specific mechanisms regulating human DC 
functions, including activation and migratory behavior. Studies of human DC 
activation and migration in tissues, especially in lung tissue, are difficult to perform, 
and we need to improve human tissue models that allow analysis of DC in a 
microenvironment that mimics in vivo situations. The aim of this project was to 
further develop our human 3D lung tissue model to enable live imaging analysis of 
DC and investigate DC activation and migratory behaviour in response to 
inflammatory stimuli and chemokines. 
 
5.2.1 The lung tissue model enables quantitative live imaging analysis of 
human dendritic cells in the microenvironment 
To establish the lung tissue model for live imaging analysis, lung epithelial cells and 
fibroblasts were transduced with fluorescent proteins using a retroviral vector system 
that enable stable transduction of the cells. Epithelial cells and fibroblasts were 
transduced with green and orange fluorescent protein, respectively. DC were labeled 
with a far red cell tracker dye before being implanted into the model. The lung tissue 
model was generated according to Figure 1B, paper II. After the completion of the 
model set up, models were removed and mounted in a six-well glass bottom culture 
plate for live imaging (Figure 1C-L, paper II). Confocal image analysis of the lung 
tissue model revealed that tissue architectures comprised a dense epithelial layer 
(green) on top of a collagen matrix of fibroblasts (red). Dendritic cells, were located 
close to the epithelial layer (Figure 2A and B and supplementary video 1, paper II), 
as we have observed before (paper I). The confocal images also revealed that the 
epithelial cells were well separated from the underlying fibroblast layer. This raised 
the question regarding whether or not there are interactions going on between the two 
layers since interactions between cells within the microenvironment have been 
reported to be essential for cell function such as differentiation, proliferation, 
adhesion and migration [84, 227, 228]. We therefore analyzed in more detail the 
connection between the epithelial cells and the underlying fibroblast matrix by 
excluding the upper epithelial layer in the image analysis. Interestingly, at the 
epithelial-fibroblast boundary, we observed elongated epithelial cells forming a 
network of fibers that stretched down into the fibroblast matrix underneath (Figure 
2C and D, supplementary videos 2 and 3, paper II). Together, these data indicated 
that our lung tissue model display a well-defined tissue structure and is well suited to 
study DC activation and migration in a physiological milieu mimicking human lung 
tissue.  
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5.2.2 Relocation of dendritic cells towards the epithelial layer in response to 
TLR-1/2 and CCL2 
To explore DC migratory behaviour in response to inflammatory stimuli and 
chemokine in a physiological milieu, the tissue model was stimulated with TLR-4 
ligand, TLR-1/2 ligands and recombinant human CCL2. Confocal image analysis for 
4 hours of stimulation with TLR-1/2 revealed that DC in the stimulated model were 
distributed closer to the epithelial layer compared to the unstimulated model (Figure 
3A and B, paper II). Quantitative analysis comparing the distance of each DC in 
relation to the center of the epithelial layer revealed that TLR-1/2 and CCL2, but not 
TLR4, induced relocation of DC resulting in DC being distributed closer to the center 
of the epithelial layer. These data demonstrate that the response of DC to different 
inflammatory stimuli and the pathways involved in regulating DC migration to 
different stimuli in lung tissue may differ. 
 
5.2.3 Stimulation of TLR-ligands and CCL2 induces dendritic cell motility in 
the lung tissue model 
To further assess the role TLRs and chemokines have on DC migration, we 
performed live imaging experiments on lung tissue models stimulated with TLR-4 
ligand, TLR-1/2 ligands or CCL2 over a time period of 16 hours. Interestingly, DC in 
the stimulated models explored a wider territory in x and y plane as shown in the 
track displacement graphs (Figure 4A-D, paper II). Furthermore, analysis of 
automatic tracking of the different stimulation revealed that DC migrated a longer 
distance and increased their mean velocity over time compared to DC in unstimulated 
models (Figure 5C-D, paper II). In addition, we could also observe that DC in 
stimulated models exhibited a less spherical shape (Figure 5E, paper II), which 
correlated with an increase in DC mean velocity (Figure 5F-I, paper II). These data 
demonstrate that DC in the tissue model respond to inflammatory stimuli and 
chemokines by relocating in relation to the epithelial layer and by displaying a more 
exploratory phenotype. Stimulations also induced changes in DC morphology 
correlating to increased velocity and longer distances of migration. Thus, our data 
demonstrate that our human lung tissue model is well-suited for quantitative 4D (x, y, 
z and time) fluorescence imaging of DC migratory behaviour in response to 
inflammatory stimuli and chemokines in real time, under next to in vivo settings.  
 
 
5.3 DENDRITIC CELL-TUMOUR INTERACTION IN THE THREE-
DIMENSIONAL TISSUE MODEL 
The identification and testing of new targetable steps aimed at preventing cancers from 
altering the microenvironment and immune cell functions, including the regulation of 
human DC and non-hematopoietic tissue specific cells, such as fibroblasts, are 
generally difficult to recapitulate in vitro. The aim of this project was to generate 
micro-tumours in the form of NSCLC, which could be implanted into our human lung 
tissue model containing DC, and investigate DC-tumour interaction in the tissue model.  
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5.3.1 Generation of micro-tumour spheroids for implantation of tumor 
epithelial cells in the lung tissue model 
To approach the challenge of creating a model for studying DC interactions with   
NSCLC cells, we decided trying to generate tumour spheroids, which could be 
implanted into the lung tissue model, and monitored by live imaging analysis. For this 
purpose we used the A549 adenocarcinoma lung epithelial cell line and the normal 
16HBE epithelial cell line that we labeled with a red cell tracker dye before creating 
the spheroids. To create the spheroids we used a hanging drop system, which 
generated spheroids of well-defined structure and a certain number of cells. First, the 
fluorescent A549 and 16HBE cells were mixed with a viscous 
carboxymethylcellulose solution and 25 µl droplets containing 500 cells each were 
placed up side down in a petri dish and incubated at 37°C for 48 hours (Figure 1A-C, 
paper III). The spheroids made of 16HBE (data not shown) or A549 cells (Figure 
1D) were then implanted in the tissue model at the same day of air-exposure. After 
four days of air-exposure, models were removed from the six-well inserts and mounted 
for live imaging experiments. Confocal image analysis of a tumor spheroid model 
revealed distinct microepithelial environments (red) that were separated from the 
normal epithelial layer (green), while DC distributed both inside the tumor area and in 
the normal epithelial layer (Figure 1F, paper III). These data indicate that the tumour 
spheroids enable implantation of tumour cells that form well-define tumour areas in the 
lung tissue model and that can be monitored in real time. 
 
5.3.2 Migration of dendritic cells in the tumour microenvironment 
Next, we investigated the impact on DC migratory behaviour in the presence of 
NSCLC. Images were acquired of models with A549 (Figure 2A, paper III) and 
16HBE spheroids (data not shown). Each spheroid area was identified (Figure 2B) and 
DC distribution was then quantified in the “tumour” area and the “healthy” area. 
Quantification of DC distribution revealed that DC were more frequently located within 
the tumour spheroids as compared to implanted 16HBE spheroids in the control model, 
(Figure 2C, paper III). This indicates that DC are attracted to the tumours and that this 
may depend on differentially secreted chemokines from the tumor cells compared to 
healthy epithelial cells.  
To elucidate the influence of tumour cells on DC behaviour and function, we 
investigated DC’s ability to take up tumour cells. For this purpose, confocal images of 
the spheroid areas with A549 (Figure 3A, paper III) or 16HBE (data not shown) were 
extracted to visualize DC located in the epithelial cell spheroids only (Figure 3B, paper 
III). Rendered images were further segmented using the Imaris software to identify 
DC that had engulfed epithelial cells within the spheroid areas of implanted 16HBE 
(Figure 3C) or A549 (Figure 3D) cells. Quantification of DC colocalization to 
implanted epithelial cells revealed that DC were more frequently associated with 
tumour cells and also engulfed A549 cells more efficiently as compared to 16HBE 
cells, (Figure 3E, paper III). Thus, NSCLC tumour spheroids can be created for 
implantation in our lung tissue model, and this enables functional studies of DC 
interactions with cancer cells in a 3D-tumour microenvironment of NSCLC, previously 
not achievable. 
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5.4 STROMAL CELLS SUPPORT INCREASED DEVELOPMENT OF 
REGULATORY DENDRITIC CELLS FOLLOWING LEISHMANIA 
INFECTION    
Stromal cells have been recognized for their function to regulate the differentiation of 
HSPC into terminally differentiated blood cells. The stromal cells niches in the bone 
marrow and the spleen control homing, migration and differentiation of hematopoietic 
progenitor cells under steady state conditions. The aim of this study was to investigate 
the role of stromal cell-derived chemokines in the differentiation of hematopoietic 
progenitor cells into regulatory DC in the spleen of mice during homeostasis and in 
response to L. donovani infection.   
 
5.4.1 Stromal cell guided hematopoietic progenitor cell differentiation into 
regulatory dendritic cells 
In a previous study, Svensson et al. [12], demonstrated that freshly isolated splenic 
stromal cells from mice have the capacity to support HSPC differentiation into 
regulatory DC. As a follow up study, we sought to investigate if the fibroblast-like bone 
marrow stromal cell line MBA-1 [218] also had the ability to support HSPC 
differentiation into regulatory DC. MBA-1 cells have shown to have the ability to 
stimulate hematopoiesis and reduce rejection of mismatched allograft transplantation 
[229]. As shown in Figure 1A and B, paper IV, BMLin−CD117+ HSPC developed to 
CD11c+MHC-II+ DC in cocultured with MBA-1 cells for 6 days. These DC expressed a 
heterogeneous level of CD11c and high levels of CD11b (Figure 1C, paper IV). To 
determine the regulatory capacity of these cells, CD11c-purified DC, (Figure D, paper 
IV), derived on MBA-1 cells were cultured with CD4+ T cells from BALB/c mice and 
CSF-2-derived LPS stimulated DC in an MLR reaction. This revealed that CD11c+ DC 
that developed on stromal cells could inhibit the MLR induced by CSF-2-derived DC 
by 90%, (Figure 1E, paper IV). In addition, we also observed that the CD11c− fraction 
also suppressed the MLR induced by CSF-2 derived DC by 70% (Figure 1F, paper I). 
These data indicated that MBA-1 stromal cells have the capacity to support HSPC 
differentiation into DC with regulatory properties.  
Chemokines secreted by stromal cells are important for HSPC migration and 
homing to hematopoietic niches [230, 231]. However, the role of chemokines in HSPC 
differentiation into regulatory DC has not been reported. Therefore, we sought to 
investigate if the development of regulatory DC from HSPC was influenced by stromal 
cell-derived chemokines. We used a transwell system in which MBA-1 cells were 
seeded in the lower chamber and BMLin−CD117+ HSPC were seeded in the upper 
chamber. We could detect CD45+H2Kb+ cells in the lower chamber after 3 hours, 
(Figure 2A) and 16 hours, (Figure 2B), of coculture, indicating that HSPC migrated 
towards MBA-1 cells in the lower chamber. After 6 day of coculture, we collected 
CD11c+ and CD11c− cells expressing CD11b in the lower chamber of the transwell 
system, Figure 2C, paper IV. This demonstrated that HSPC that had migrated towards 
the MBA-1 cells differentiated into CD11c+CD11b+ and CD11c−CD11b+ cells. In 
contrast, HSPC remaining in the insert differentiated only into CD11c−CD11b+ cells  
(Figure 2C, paper IV). These observations indicate that soluble factors from MBA-1 
cells are sufficient to support differentiation of CD11c−CD11b+ cells, whereas 
differentiation of CD11c+CD11b+ cells required contact with stromal cells. We also 
confirmed that DC generated from the migrated HSPC in the Transwell system have 
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the capacity to suppress an MLR reaction induced by CSF-2 derived DC (Figure 2D, 
paper IV).   	  
5.4.2 L. donovani infection enhanced hematopoietic stem and progenitor cell 
differentiation into regulatory dendritic cells 
L. donovani is a protozoan parasite that can infect bone marrow [232] and splenic 
stromal cells [12]. L. donovani infection enhance the capacity of splenic stromal cells 
to support HSPC differentiation into regulatory DC [12]. However, it was never 
ascertained if this was due to direct infection of the stromal cells by the parasite or if 
it could be influenced by inflammatory cytokines at the site of infection. To address 
this question, we infected MBA-1 cells and RAW264.7 macrophages with L. 
donovani amastigotes (Figure 3A, paper IV) and investigated if the infected cells had 
enhanced capacity to support HSPC differentiation into regulatory DC. The analysis 
revealed that HSPC differentiation into CD11c+ DC was increased in coculture with 
infected MBA-1 cells compared to uninfected cells. However, coculture with 
RAW264.7 cells did not support HSPC differentiation into CD11c+ DC (Figure 3A, 
paper IV). As shown in figure 3C, paper IV, DC derived on infected MBA-1 cells 
also had regulatory capacity. This finding indicates that direct infection of stromal 
cells enhances their capacity to support HSPC differentiation into regulatory DC. 	  
5.4.3 Expression of stromal cell-derived chemokines is modulated by 
Leishmania donovani infection 
Next, we investigated chemokines that are expressed in MBA-1 cells but not in 
RAW264.7 cells before and after infection of L. donovani based on the observation 
that RAW264.7 did not support HSPC differentiation in the Transwell assay. For this 
purpose, we performed genome-wide mRNA expression profiling of uninfected and 
infected MBA-1 and RAW264.7 cells. As a result of this we identified a variety of 
genes with changed expression in response to infection in both cell lines but we 
focused our analysis primarily on changes in the chemokine expression. This analyses 
revealed eight chemokine genes CCL7, CCL8, CCL27, CXCL1, CXCL3, CXCL5, 
CXCL12 and CXCL15 that were differentially expressed in MBA-1 cells compared 
to RAW264.7 cells (Figure 4A, paper IV). We got interested in one particular 
chemokine, CCL8, which was increased in MBA-1 cells in response to infection 
according to the microarray analysis. In addition, studies have shown that CCL8 was 
expressed in splenic stromal cells that can support DC development [233]. Based on 
this observation and the knowledge that CXCL12 is important in regulating HSPC 
homing and migration [98, 230, 234], we initially focused our studies on CCL8 and 
CXCL12. First, we confirmed the microarray data with real time QTR-PCR and 
ELISA analysis that revealed expression of CCL8 and CXCL12 mRNA and protein 
by MBA-1 cells. In contrast, the chemokine expression was undetectable in 
RAW264.7 cells (Figure 4B-E, paper IV). The real time QRT-PCR analysis also 
revealed that CCL8 expression was increased in infected MBA-1 cells compared to 
uninfected cells, whereas CXCL12 was slightly reduced 48 hours post infection 
(Figure 4F, paper IV). Together, the analyses revealed a unique stromal cell 
chemokine expression pattern that was modulated by Leishmania donovani infection.   
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5.4.4 L. donovani infection induced CCL8 expression in splenic stromal cells 
The expression of CXCL12 and CCL8 has not been reported during L. donovani 
infection in vivo. To investigate the expression of these chemokines in splenic tissue 
of mice infected with L. donovani, we performed real time QRT-PCR analysis and 
interestingly the results revealed an increased expression of CCL8 by 100-1000 times 
in infected mice. The expression of CXCL12 was unaltered or minimally reduced in 
response to infection (Figure 5A, paper IV). To investigate the CCL8 expression in 
splenic stromal cells, we analyzed mRNA level of CCL8 in ex vivo enriched splenic 
stromal cells. The analysis revealed that CCL8 expression was increased 10,000 fold 
in splenic stromal cells from infected mice (Figure 5A, paper IV), thus, indicating a 
10-fold enrichment of signal by purification of stromal cells compared with the CCL8 
expression seen in the whole spleen. In addition, immunohistology analysis revealed 
CCL8 protein expression in splenic tissue from mice infected with L. donovani, 
whereas tissue from naive spleen showed no expression of CCL8 (Figure 5B, paper 
IV). CCL8 protein could also be detected in medium conditioned with freshly 
isolated splenic stromal cells from infected mice (Figure 5C, paper IV). Furthermore, 
CXCL12 protein was still expressed in enriched splenic stromal cells from naive and 
infected mice (Figure 5F, paper IV). These findings indicate that L. donovani 
infection modulates chemokine expression of splenic stromal cells, in particular that 
of CCL8.  	  
5.4.5 Induction of stromal cell-derived CCL8 during L.donovani infection is 
associated with increased recruitment of hematopoietic stem and 
progenitor cells 
As the expression of CCL8 is increased during L. donovani infection, we decided to 
investigate the role of CXCL12 and CCL8 in the migration of HSPC. We investigated 
the contribution of these chemokines in the migration of HSPC induced by MBA-1 
cells in a transwell migration assay. Neutralizing antibody against CXCL12 revealed 
efficient blocking of HSPC migration induced by MBA-1 cells (Figure 6A, paper 
IV) to the level that was observed for pertussis toxin, an inhibitor of chemokine 
receptor signaling (Figure 6B, paper IV). This confirms the crucial role of CXCL12 
in the induction of HSPC migration that has previously been reported [98, 230]. 
Interestingly, we also observed that neutralizing antibody against CCL8 had a partial 
blocking effect against HSPC migration induced by MBA-1 cells (Figure 6C, paper 
IV).  
To further investigate the role of CXCL12 and CCL8 in the migration of HSPC, 
conditioned medium from MBA-1 cells was used in the migration assay. The reason 
of using conditioned medium instead of the cells was to avoid involvement of other 
chemokines that may be induced following contact between HSPC and the stromal 
cells.  The analysis revealed that conditioned medium induced a higher migration of 
HSPC compared to the concentration of recombinant CXCL12 that was detected in 
MBA-1-conditioned medium (Figure 6D, paper IV). This observation indicates that 
other chemokines may be involved in the migration of HSPC. In addition, using a 
neutralizing antibody against CCL8 in the MBA-1-conditioned medium, reduced 
HSPC migration to the level detected with recombinant CXCL12 (Figure 6D, paper 
IV).  We also observed that CCL8 alone did not induce HSPC migration, however, in 
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combination, CXCL12 and CCL8 induced HSPC migration to the levels seen with 
MBA-1-conditioned medium (Figure 6E, paper IV).  These data indicate that stromal 
cell-derived CCL8 synergized with CXCL12 in the recruitment of HSPC.  
Next, we sought to determine if the CCL8 induction observed in L. donovani 
infection in mice could affect the recruitment of HSPC by using a transmigration 
assays with conditioned medium from splenic stromal cells isolated from uninfected 
and infected mice. The analyses revealed that HSPC migration was induced in 
cocultures with medium conditioned with splenic stromal cells isolated from infected 
mice (Figure 6G, paper IV).  Furthermore, we observed that neutralizing antibodies 
against CCL8 reduced HSPC migration in medium conditioned with splenic stromal 
cells from infected mice to the level that was observed for medium conditioned with 
splenic stromal cells of naive mice (Figure 6G, paper IV).  The analysis also 
revealed that neutralizing antibody against CXCL12 in medium conditioned with 
splenic stromal cells from infected mice blocked HSPC migration to the level that 
was observed for medium only (Figure 6G, paper IV). In this study, we found that 
the stromal cell-derived chemokines CXCL12 and CCL8 cooperate to recruit 
hematopoietic progenitors that can differentiate into regulatory DC. In addition, L. 
donovani infection of bone marrow stromal cells showed increased production of 
CCL8 and enhanced capacity to support the development of regulatory DC. Also, 
CCL8 production was induced in splenic stromal cells from L. donovani infected 
mice, which may lead to increased capacity to recruit HSPC with the potential of 
developing into regulatory DC. 
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6 DISCUSSION OF OUR RESULTS 
This chapter is divided into two sections. In the first section, I will discuss the results 
obtained using the 3D lung tissue model with DC. The second section will focus on the 
discussion of results obtained from experiments of stromal cell regulation of HSPC 
differentiation into regulatory DC in response to L. donovani infection. 
 
 
6.1 THE THREE-DIMENSIONAL LUNG TISSUE MODEL WITH DENDRITIC 
CELLS 
Tissue microenvironments, such as gut and lung mucosa, are increasingly recognized as 
important factors in influencing and coordinating tissue homeostasis and inflammation. 
This coordination depends on a delicate interaction between immune cells, tissue-
specific cells and ECM. Therefore, the establishment of 3D-human tissue models has 
become increasingly appreciated to study infectious diseases and tissue 
pathophysiology, as they are likely to better capture the cellular events that occur in real 
tissue compared to those that occur in monolayer cultures. The establishment of 3D 
tissue models of human lung, skin and oral mucosa composed of a physiological 
fibroblast matrix and a stratified epithelial layer has been accomplished [138, 139, 
235]. However, in vitro models of human lung that include human immune cells are 
lacking. Therefore, we have developed a 3D tissue model of human lung by implanting 
human DC in a multicellular microenvironment composed of lung fibroblasts and lung 
epithelial cells. The findings from this work demonstrate that our 3D lung tissue model 
can be used to study tissue regulation of DC functional properties in a physiologically 
relevant environment. We also showed that the tissue model is useful for visualizing the 
migratory behaviour of DC in response to inflammatory stimuli in real time using live 
cell imaging confocal microscopy. Furthermore, we demonstrated that generation of 
tumour spheroids from cancer cells could be implanted in the lung tissue model and 
enable analysis of DC interaction with tumour cells in the lung tissue 
microenvironment in real time.  
 
6.1.1 The lung tissue model recapitulates the structure of airway mucosal 
tissue and supports the survival of dendritic cells  
Exposure of cells to the spatial constraints imposed by a 3D milieu determines how 
cells perceive and interpret biochemical cues from the surrounding microenvironment, 
e.g., the extracellular matrix, adhesion molecules, growth factors, inflammatory 
mediators, and metabolites as well as pathogens. It is in this biophysical and 
biochemical context that cells display bona fide tissue and organ specificity. Even 
though this is the way we tend to view the situation for non-hematopoietic cells, it 
should also be applicable to our view on hematopoietic cells when it comes to 
understanding their functional properties associated to specific tissues. The lung tissue 
model that we have developed provides a proper tissue microenvironment, although 
less complex, than real tissue. Nevertheless, it allows DC to perform their functions 
while embedded in an multicellular microenvironment of fibroblasts, epithelial cells 
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and extracellular matrix components, all of which are essential for normal tissue 
function.  
In vivo, collagen IV and laminin 5 are produced mainly by the fibroblasts. These 
proteins are the major components of the basement membrane, which for example is 
essential for the formation of epithelial cell barriers [86]. Collagen IV and laminin 5 
also influence cell differentiation, adhesion and movement [236-238]. Tropoelastin is 
another important component of the ECM and the basement membrane, and play a key 
role in the control of tissue elasticity [239].  Epithelial cells not only need the basement 
membrane to function properly, but they also need to hold together. Epithelial cells in 
vivo are held together by adherence junction proteins such as E-cadherin, that play a 
key role in epithelial anchoring and adhesion within the tissue. The structural integrity 
of epithelial cells is crucial for the maintenance of a functional epithelial barrier. To 
perform this task, the adherence junction proteins are accompanied by tight junction 
proteins. The latters have a pivotal role in the regulation of epithelial cell permeability 
and transportation of ions and water. The major components in the tight junctional 
complex formation are the Occludin and Claudin proteins [240]. Formation of 
junctional complexes is specific to the epithelium and provides useful markers for 
recognizing epithelial cells in vitro. The findings that our lung tissue model produced 
and deposited all of the essential proteins mentioned above, indicate that the tissue 
model has a functional structure that resembles epithelial tissue of real lung.  
Further observation of the lung tissue model with DC includes that we identified DC 
being widely distributed in the tissue model, most of which were located close to the 
epithelial layer, which is in line with a previous report [226]. It may suggest that DC, 
are patrolling the epithelial cell barrier being ready to respond to foreign material and 
tissue damage, followed by their coordinated production of cytokines and chemokines. 
There is evidence suggesting that DC can express tight junction proteins, such as 
Claudin and Zonula-2, which enables DC to form tight junctions with the airway 
epithelial cells. This enables DC to open up the epithelial tight junction barrier without 
disturbing the epithelial integrity and enter the airway lumen to sample inhaled antigens 
[241, 242].    
To identify DC in the tissue model, we used antibodies specific for HLA-DR, DC-
SIGN and CD11c that are well-defined DC markers not expressed by the non-
hematopoietic cells. The DC survived in the tissue model for at least eleven days 
without exogenous growth factors. This number differs substantially from the ones seen 
when culturing DC in medium only; as monocyte-derived DC normally do not survive 
in culture without CSF-2 and IL-4 for more than three days. The tissue model is likely 
to produce cytokines and growth factors that support DC survival. For example, we 
identified that the tissue model abundantly expresses mRNA for the cytokine CSF-2 
but not for IL-4. CSF-2 has been suggested to play a crucial role in the survival of 
steady state DC in the lung, skin and lamina propria [81]. Furthermore, in lung tissue, 
DC have a rapid turnover at steady state where resident population are renewed within 
one week [243, 244]. Nevertheless, at day 8 there are still many DC in the tissue model, 
which can be monitored upon intervention, and additionally, imaging of DC turnover 
may be a useful tool for investigating the effect of harmful compounds on DC survival.  
Together, these results demonstrate that our 3D lung tissue model supports survival 
of DC and allows functional studies of human DC in a physiologically relevant milieu 
previously not achievable. Furthermore, we believe these findings have important 
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implications for increasing our understanding of tissue-specific regulation of local 
immune responses in lung tissue in general, and DC function in particular.  
 
6.1.2 Lung tissue model regulates chemokine production by dendritic cells 
The secretion of chemokines orchestrates the migration of leukocyte migration 
between lymphoid and peripheral tissues at steady state and during infection. 
Dendritic cells are producers of several chemokines and recent studies indicate that 
the quality of chemokine production in tissue is determined by the local 
microenvironment. Our study shows that the 3D lung tissue model regulates the 
ability of DC to produce the chemokines, CCL18, CCL17 and CCL22.  At steady 
state, the chemokine CCL18 is produced at high levels in lungs [184], whereas 
CCL17 and CCL22 [182, 185] are highly expressed in thymus and lymph nodes, and 
at relatively low levels in lung. Our results suggest that the lung tissue model supports 
DC production of CCL18 since DC in the tissue model produce more CCL18 than 
DC cultured in medium only. In contrast, DC production of CCL17 and CCL22 was 
reduced when DC were implanted into the tissue model compared to the production 
by DC cultured in medium. These findings indicate that the microenvironment in the 
lung tissue model selectively regulates chemokine production by DC, in ways 
resembling the production of chemokines under physiological conditions in lung 
tissue. Thus, our results implicate that specific tissue niches in the lung may regulate 
the outcome of immune responses by influencing functional properties of DC locally. 
However, the mechanism that controls the expression of CCL18, CCL17 and CCL22 
in lung tissue needs further investigations. Furthermore, our study demonstrates that 
DC expression of CCL18 is enhanced by soluble factors that are secreted by the lung 
tissue model. However, the mechanisms regulating CCL18 production by DC in lung 
tissue are still unknown. There are several factors in the lung tissue model that could 
lead to the induction of CCL18. At present we are investigating two potential 
signaling pathways in DC that may lead to increased CCL18 expression. One 
pathway could be mediated by a stromal cell-derived cytokine called thymic stromal 
lymphopoietin (TSLP), which has been shown to induce CCL18 expression in human 
monocytes [245]. Thymic stromal lymphopoietin is produced by epithelial cells and 
fibroblasts and is constitutively expressed by many tissues including skin, lungs, 
intestines and thymus [246, 247]. The cytokine preferentially stimulates myeloid cells 
and is a potent regulator of DC function [111]. The signaling pathway of TSLP is 
mediated via a receptor that is composed of two subunits, TSLP receptor and IL-7Rα 
(CD127). Receptor ligation leads to phosphorylation of STAT5 and STAT3. Our 
preliminary results showed that the lung tissue model express TSLP and TSLP was 
found to be produced by both lung fibroblasts and lung epithelial cells. Currently we 
are investigating the role of TSLP in inducing CCL18 by DC in our model system. 
These studies also include analysis of TSLPR receptor expression on DC in the 
model. Another signaling pathway that may lead to CCL18 expression could be 
mediated by collagen type I and IV in the tissue model. Collagen type I and IV have 
been shown to induce CCL18 expression in myeloid cells, such as macrophages, by 
binding to αβ/integrin, which induces STAT6 signaling cascade that could lead to 
CCL18 production [248] (Figure 6). Using blocking antibodies against TSLP/TSLPR, 
as well as integrins and collagens, we will investigate the role of such molecules in 
the regulation of CCL18 by DC.  
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CCL18 is a chemokine that is mostly associated with anti-inflammatory and Th2 
immune responses[249]. Recent studies have demonstrated a role for CCL18 in the 
differentiation of DC into tolerogenic cells that have the ability to prime regulatory T 
cells [195]. This suggests that the constitutive expression of CCL18 observed in lung 
tissue may play an important role in the maintenance of tolerance to inhaled antigens 
under homeostatic conditions. Hopefully, it should be possible explore the pathways 
controlling CCL18 production by DC using the lung tissue model and future 
observations can then be verified in normal lung tissue. 
 
6.1.3 Live imaging analysis of dendritic cell migration in the lung tissue model 
Having established a robust and reliable tissue model system that enables studies of 
DC functional properties in a physiologically relevant lung microenvironment, we 
wished to further develop our 3D lung tissue model for live cell imaging analysis, 
which would allow imaging of DC behaviour under next to in vivo settings. This led 
to the second major outcome of my thesis work and includes that DC migratory 
behaviour in response to inflammation and chemokines can be studied in the lung 
tissue model using a live cell imaging technique. Here, we showed that lung epithelial 
cells and fibroblasts are responsible for the formation of intricate cellular networks, 
which allows for DC distribution in a multicellular microenvironment. This model set 
up enables studies of human DC activation and migration in response to 
inflammatory stimuli and chemokines in live tissue. Our results demonstrate that the 
lung tissue model established for live imaging shares similar characteristics to typical 
epithelial lung tissue, such as the formation of a well-defined stratified epithelium 
Figure 6. Schematic illustration of potential mechanisms that may lead to CCL18 induction in DC. The 
cytokine TSLP that is constitutively expressed by fibroblasts and epithelial cells may bind to the TSLP 
receptor on DC and signal via STAT5 to induce CCL18 production. Another potential signaling 
pathway may be mediated by collagen IV that binds to the intergrin receptor on DC and signals via 
STAT6. 
 
Figure 6 
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that is well separated from the underlying fibroblast matrix layer. The separation 
between the two layers depends on the formation of a basement membrane that is 
made up of collagen, laminin, fibronectin and proteoglycans. The basement 
membrane is usually a joint product of the epithelium and the underlying stroma [83]. 
Furthermore, our data demonstrated that epithelial cells located closest to the 
boundary between the fibroblast and epithelial cell layer displayed a more elongated 
morphology and formed a network of fibers that connects them to the underlying 
fibroblast layer. The interaction between epithelial cells and other non-hematopoietic 
cells has also been proposed to be regulated by diffusible factors, rather than via 
direct contact between the cells [83]. However, the structure of the epithelium is most 
likely dynamic and there may be constant communication between the epithelial cells 
and the underlying extracellular matrix, providing a proper microenvironment for DC 
to migrate in. 
In lung, activation of DC is driven by their encounter with inhaled antigens. To 
perform their immune surveillance and regulation of immune responses in tissues, 
DC express a variety of pattern recognizing receptors, amongst them the TLRs [250]. 
Using our established lung tissue model for live cell imaging analysis, we showed 
that DC in the tissue model responded to TLR-ligands stimulation and the chemokine 
CCL2, which resulted in a relocation of DC towards the epithelial layer. The 
chemokine CCL2 is known to mediate DC migration and maturation. It has also been 
shown that CCL2 plays an important role in the recruitment of DC to the lung during 
acute allergen challenge [177]. It is possible that the relocation of DC to the epithelial 
layer mediated by TLR-ligands does not solely depend on direct TLR-stimulation of 
DC. It could also depend on the release of chemokines by epithelial cells, which may 
contribute to the recruitment and redistribution of DC. There is evidence suggesting 
that airway epithelial cells also express TLRs and upon TLR-stimulation epithelial 
cells release chemokines and cytokines, such as CCL20 and CSF-2, that may mediate 
the recruitment of DC to the epithelial tissue [108, 251]. Using the live imaging set up 
of the lung tissue model system, we could show that DC are attracted to the epithelial 
layer in response to TLR-1/2 stimulation and CCL2, but not in response to TLR-4.  
The differences observed between TLR1/2 and TLR-4 ligand may be due to the fact 
that the concentration of TLR-4 ligand used in the experiment was not sufficient to 
induce chemokine expression by epithelial cells that could recruit DC to the epithelial 
layer. However, we showed that DC in the tissue model explored a wider territory in 
the x and y plane and moved longer distances in response to TLR-1/2, TLR-4 and 
CCL2, suggesting that DC responded in one way or another to all stimuli applied. 
The results also revealed that DC in the tissue model moved faster in response to the 
stimuli. The rapid movement by DC, that was observed, in response to TLR-ligands 
and CCL2 may be a necessary mechanism for DC to scan the microenvironment in 
the search for foreign antigens. How this migratory behaviour of DC is induced in 
response to TLR stimulation and which tissue specific-derived factors that are 
involved in this regulation remains to be determined. One possible theory could be 
that the surrounding tissue-specific cells secrete chemokines, which are deposited or 
possibly transcytosed to build gradients of chemokines that DC can migrate along. 
Also, adhesion molecules are likely to support and guide the migration of DC in the 
tissue microenvironment. For example, bronchial epithelial cells have the ability to 
express chemokines that mediate both leukocyte migration and adhesion. CX3CL1 is a 
chemokine that exerts dual function and can act as adhesion molecules through their 
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membrane-bound form or as soluble chemotactic factors. Our data indicated that 
CX3CL1 is highly expressed by the lung tissue model and that CX3CR1, the receptor 
for CX3CL1, is expressed by DC in the model, which suggests that CX3CR1 and its 
ligand may contribute to the epithelial organization of DC observed in the lung tissue 
model.  
Our findings demonstrate that the lung tissue model enables studies on DC 
distribution and migration in response to different inflammatory stimuli and 
chemokines. The quantification of DC migration and distribution in the tissue model 
can provide a powerful tool to investigate the mechanistic actions of adjuvants or 
demonstrate effects of noxious compounds as well as testing reagents aiming at 
blocking DC activation and migration locally.    
 
6.1.4 Exploring dendritic cell behaviour and function in an organotypic-based 
epithelial spheroid model of non-small cell lung cancer  
There is evidence supporting that cancers affect the immune system by imposing 
deregulated immune responses. However, the mechanisms that mediate interactions 
between tumours and human hematopoietic cells within the tumour tissue are poorly 
defined. In the tumour microenvironment, the surrounding tissue-specific cells and 
ECM are also likely to play an important role in the regulation of immune cell 
differentiation and function during tumour development [119, 252]. However, most 
studies on cancer have been performed using one cell component at a time and may not 
capture the complexity of numerous cellular processes that occur in vivo. Therefore, we 
believe that tissue model systems that recapitulate many key anatomical and functional 
features of the in vivo parental tissue are indispensable to study cancer. To allow 
studies of DC-tumour cell interactions in a 3D milieu, we developed our 3D tissue 
model to also include cancer cells. Using a hanging drop system we generated 
microtumours in the form of epithelial spheroids and implanted these as micro 
tumours. The use of epithelial spheroids enables us to implant a fixed number of cells 
into the tissue model. In this study, A549 was used as a model system for NSCLC 
and 16HBE epithelial cells were used as a control for “healthy” cells. The two 
epithelial cell lines formed a well-defined spheroid structure when cultured in a 
viscose cellulose solution using the hanging drop system. The advantage of using 
spheroids for studying tumour biology is that spheroids grown from tumour cell lines 
show growth kinetics similar to those of in vivo tumours [121]. The implantation of 
spheroids in the lung tissue model revealed formation of distinct microtumour 
environments in the epithelial layer. The microtumours in the tissue model are well 
separated from the rest of the “healthy” epithelial layer and are likely held together by 
surface membranes, extracellular matrix and junctional complexes.  Implantation of 
tumour epithelial spheroids and normal epithelial cells revealed that the tumour cells 
attracted DC to the microtumour area much more efficient than the normal epithelial 
cells. This may be due to tumour-derived chemokines or adjacent fibroblasts and 
epithelial cells in the tissue model that secrete chemokines, attracting DC to the 
tumour area. In preliminary experiments we have been able to detect chemokine 
production in the lung tissue model with micro-tumours.  We are currently 
investigating the differences between chemokine production in models with tumour 
spheroids and in models with normal epithelial cell spheroids. We will also isolate the 
different cell populations from both models to compare activation markers of DC and 
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investigate chemokine expression in the different cell types from the lung tissue 
model with and without tumours.   
In tumour tissues, DC can engulf necrotic tumour cells, which induces the 
maturation of DC that have the ability to activate CD4+ and CD8+ T cells [253]. In 
addition, we observed that DC engulf the tumour cells more readily, which may 
indicate the presence of molecular signals displayed or secreted by necrotic cells, 
leading to enhanced engulfment of the adenocarcinoma cells by DC. Furthermore, we 
have shown that the tissue model can be digested and DC and tissue specific cells in 
the model can be isolated. This method will enable us to investigate phenotypic 
markers of DC as well as cytokine and chemokine expression secreted by tumour 
cells in more detail.  
We believe, our newly developed lung tumour model system provides a powerful 
tool to investigate the mechanisms behind the attraction and modulating of DC 
functional properties by NSCLC and capture early events in the course of tumour 
progression in lung tissue. For example, the role of certain chemokines in the tumour 
tissue model could be examined by gene manipulation to alter chemokine expression 
in A549 cells or by using blocking reagents against candidate chemokines and 
chemokine receptors. Alternatively, gene expression can be manipulated in 16HBE 
cells to perform gain of function experiments. It will also be interesting to follow up 
on and elucidate the molecular signals that lead to enhanced engulfment of cancer 
cells by DC in the tumour microenvironment. This may be of importance in the 
context of DC-uptake-processing and presentation of tumour associated antigens to T 
cells.  
For this part of the thesis work, I have developed a human 3D lung tissue model, 
which comprises bronchial epithelial cells, fibroblasts and DC. This tissue model is 
highly reproducible and although quite laborsome, it is a relatively inexpensive model 
system that provides a novel platform for studies on tissue-specific regulation of 
human DC functional properties in a physiological microenvironment that resembles 
the morphological and functional features of the one found in in vivo parental tissues. 
The cells in this model system can further be modified to express fluorescent proteins 
that enable live cell imaging studies of DC migration in tissue. Assay of human DC 
behaviour in live tissue is difficult to perform, but this difficulties may be overcome 
by the use of tissue model systems as described here. This is important because there 
is evidence demonstrating that DC migration is largely influenced by the tissue 
origin, degree of maturity and the 3D-structure of the microenvironment [254]. Even 
though, not every aspect of DC biology can be investigated using 3D tissue models, 
our model system can provide a powerful tool to explore at least some important 
mechanisms of DC regulation in tissue, some of which include pathways dictating 
DC anchoring and migrating behaviour as well as chemokine producing and immune 
stimulatory capacities.  As our lung tissue model recapitulates many key functional 
and anatomical features of lung tissue and it is well suited for a wide range of studies 
including those on DC interaction with cancer cells and DC immune function in the 
tumour microenvironment.  
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6.2 STROMAL CELL-DERIVED CHEMOKINES SUPPORT 
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION INTO 
REGULATORY DENDRITIC CELLS 
As discussed in the previous sections, chemokines play an important role for the 
migration and functional properties of terminally differentiated hematopoietic cells in 
peripheral tissues. In addition, they also play a crucial role in the homing and 
migration of HSPC in the bone marrow and spleen [216, 230] [231]. Here, I will 
discuss our results regarding the role of stromal cell-derived chemokines in the 
regulation of hematopoietic progenitor cell differentiation into regulatory DC and 
how parasite infection can modulate this process, which may be one of the 
mechanisms in which the parasite influences the stromal microenvironment and 
promotes persistent infection.  
Stromal cells are increasingly recognized for their role in influencing immune cell 
differentiation and survival during inflammation and in response to infection [11, 13, 
255]. In this study, we found that the bone marrow-derived stromal cell line, MBA-1, 
attracted HSPC by producing CXCL12 and CCL8. The chemokine CXCL12 is 
known to have a crucial role in the regulation of HSPC migration, survival and 
differentiation [98, 256]. Recent studies indicate that CXCL12 cooperates with other 
cytokines such as CSF-2, thrombopoietin and IFN-γ to enhance the survival 
capabilities of HSPC, [257, 258]. It has also been shown that HSPC migration in 
short-term culture is synergistically enhanced by the interaction between CXCL12 
and Flt3 ligand and their receptors [259]. This suggests that CXCL12 may contribute 
to HSPC survival and migration by itself as well as in combination with other 
cytokines. Synergistic interaction between CXCL12 and other chemokines such as 
CCL2 has also been investigated. Gouwy et al. demonstrated that CXCL12 and 
CCL2 synergized to enhance monocyte migration [260]. However, synergisms 
between CXCL12 and other chemokines leading to altered capacity to support HSPC 
migration and differentiation are not known. Here, we showed for the first time the 
cooperation of CXCL12 and CCL8 in guiding migration of HSPC that have the 
ability to differentiate into regulatory DC. It has been suggested that the synergistic 
effect evoked by chemokines depends on receptor dimerization [261]. Moreover, 
Sohy et al. showed that the receptor CXCR4 and CCR2 formed dimers with each 
other. CXCR4 is the receptor for CXCL12 and CCR2 is one of the receptors for 
CCL8. Both receptors have been observed to exist as constitutive homo- and 
heterodimers. It was also shown that using specific antagonists of one receptor 
inhibits the binding of chemokines to the other receptor, both in recombinant cell 
lines and primary leukocytes. In our experiments, using neutralizing antibodies 
against CXCL12 and CCL8 it was revealed that anti-CXCL12 could inhibit HSPC 
migration to the levels seen with pertussis toxin, an inhibitor of G-protein couple 
receptors, while anti-CCL8 could inhibit HSPC migration partially. This suggests that 
the CXCL12 signaling pathway is required to induce migration of HSPC and CCL8 
synergizes together with CXCL12 to enhance HSPC migration. However, the 
mechanisms of the chemokine receptor signaling that may cooperate in regulating 
enhanced HSPC migration needs further investigations.  
The second major observation in this study is that infection with L. donovani 
altered chemokine expression in MBA-1 cells and splenic stromal cells isolated from 
mice, leading to increased production of CCL8 and a slight reduction of CXCL12 
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expression. Although CXCL12 was reduced to some extent, the expression of 
CXCL12 mRNA was still highly abundant in the MBA-1 cells and the splenic 
stromal cells of mice infected with L. donovani. Our findings indicate that CCL8 is 
induced upon infection and may contributes to the enhanced recruitment of HSPC to 
the spleen [102] and the increased number of regulatory DC that has been observed 
during L. donovani infection [12, 262]. In addition, we suggest that the cooperation of 
CXCL12 and CCL8 in regulating hematopoiesis provides evidence for additional 
pathways regulating hematopoietic activity that can be targeted by intracellular 
pathogens. However, the role of CCL8 in the development and maintenance of 
chronic infection needs further investigations and depends on the development of 
tools that can block CCL8 in vivo or to generate conditional CCL8 knockout mice. 
Although CXCL12 and CXCR4 knock out mice exist, they die in utero and are 
defective in vascular development, hematopoiesis and cardiogenesis [263]. Another 
possibility could be to use CCR2 knockout mice, but one disadvantage is that CCR2 
binds to several chemokines such as CCL2, CCL7 and CCL13, which may have 
important functions in responses to pathogens; it was previously shown that CCR2 
knockout mice were susceptible to Mycobacterium tuberculosis infection which was 
associated with impaired recruitment of immune cells to the site of infection [176, 
264, 265]. Also, it has recently been shown that CCL8 binds to CCR8 rather than to 
CCR2 in mouse skin [266]. CCR8 knockout mice exist, but they are shown to have 
aberrant Th2 cell response and impaired recruitment of eosinophils [267].   
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7 CONCLUSIONS  
7.1 THE STUDIES ON THE THREE-DIMENSIONAL LUNG TISSUE 
MODEL  
The studies comprised in this thesis contribute to the knowledge of establishing a 
physiologically relevant tissue model system for studies on DC functional properties in 
human lung tissue under next to in vivo conditions. This multicellular modelling 
approach that uses an advanced cell culture technique provides a powerful tool that, in 
combination with animal models and human clinical data, can increase our 
understanding of the cellular mechanisms that underlie tissue pathology caused by 
infectious agents, tumour progression and aberrant inflammatory reactions to harmful 
reagents. The results demonstrate that our lung tissue model supports the survival of 
DC as well as DC production of homeostatic chemokines and therefore enables 
functional studies of human DC in a physiological lung mucosal environment. This 3D 
tissue model provides a flexible and high throughput experimental platform that allows 
for interventions of various kinds as well as manipulation of gene expression in tissue-
specific cells. It enables us to visualize processes of human DC function and migration 
with 4D fluorescence live imaging technique in models mimicking real tissue. The 
finding that DC migratory behaviour in the tissue model is influenced by TLR-ligands 
and chemokines provides new possibilities to explore in detail the mechanisms of 
tissue communication that underlie DC anchoring and migrating behavior in the 
microenvironment. In addition, the quantification of DC migration and distribution in 
the tissue model can provide a powerful tool to investigate the mechanistic actions of 
adjuvants or demonstrate effects of noxious compounds as well as testing reagents 
aimed at blocking DC activation and migration locally.  
Our newly established lung tissue model represents a physiologically relevant assay 
system that can be used for a wide range of studies and it has an exciting potential to 
reveal pathogenic processes in infectious and inflammatory diseases. In this regard, we 
aim to make this model accessible for others to show the usefulness of the model in 
other diseases. Currently, we are collaborating with other groups to provide new 
insights into the pathogenesis of acute severe Staphylococcal infections, tuberculosis 
and Hantavirus infection using our lung tissue model. Future research using 3D tissue 
model systems, in combination with patient samples and clinical data may provide a 
more complete understanding of the interactions that occur between the host and 
pathogens, which might lead to potential strategies for preventing and treating 
infectious diseases and cancers affecting lung tissue. 
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7.2 THE STUDY ON STROMAL CELL-MEDIATED DEVELOPMENT OF 
REGULATORY DENDRITIC CELLS 
This study in the thesis work contributes to an increased understanding of altered 
hematopoietic capacity of stromal cells in response to L. donovani infection and in 
which ways an altered stromal cell chemokine production capacity affects HSPC 
migration and differentiation. Our results emphasize the cooperation between 
CXCL12 and CCL8 leading to enhanced recruitment of HSPC that have the ability to 
develop into regulatory DC. Moreover, we found that infection with L. donovani 
induced CCL8 expression in a bone marrow stromal cell line and freshly isolated 
murine splenic stromal cells. Our finding that CXCL12 and CCL8 cooperate in 
regulating hematopoiesis provides evidence for additional pathways regulating 
hematopoietic activity that can be targeted by intracellular pathogens. 
The ability of the local tissue niches to shape the functional properties and 
repertoire of DC provides important mechanisms for tissue regulation of homeostasis 
as well as responses to inflammation and infection. However, in chronic infections, 
such as leishmaniasis, tuberculosis and malaria, the observation of altered stromal cell 
function leading to the development of DC and T cells with regulatory function, may 
be an important mechanism for preventing immune-mediated pathology that is 
exploited by the pathogens. By identifying in detail, the mechanisms that contribute 
to shaping the DC repertoire and functionality, this may allow us to invent new 
targets therapies to manipulate DC, aiming at resolving chronic infections, modulate 
overt inflammatory reactions and restore DC functions. 
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